Judith Silverstein Currier

Title(s)Professor, Medicine
SchoolMedicine
vCardDownload vCard

    Collapse Overview 
    Collapse Overview
    Dr. Judith S. Currier serves as the Executive Vice Chair for Research in the Department of Medicine and as Co-Director of the Center for Clinical AIDS Research and Education. She holds the Michael and Sue Steinberg Endowed Chair in Global AIDS Prevention and Policy Research.

    Collapse Research 
    Collapse Research Activities and Funding
    Prospective Evaluation of Antiviral Therapy and Cardiac Health
    NIH R01HL095132Sep 25, 2008 - Dec 31, 2014
    Role: Principal Investigator
    Postdoctoral Training in Global AIDS Prevention Research
    NIH T32MH080634Jul 1, 2007 - Jun 30, 2022
    Role: Principal Investigator
    UCLA AIDS Prevention and Treatment Clinical Trials Unit
    NIH UM1AI069424Feb 1, 2007 - Nov 30, 2027
    Role: Principal Investigator
    UCLA AIDS Prevention and Treatment Clinical Trials Unit
    NIH U01AI069424Feb 1, 2007 - Nov 30, 2013
    Role: Principal Investigator
    AIDS Clinical Trials Group for Research on Therapeutics for HIV and Related Infections
    NIH UM1AI068636Jun 29, 2006 - Nov 30, 2027
    Role: Principal Investigator
    Optimizing Antiretroviral Therapy in HIV
    NIH K24AI056933Aug 1, 2003 - Feb 28, 2016
    Role: Principal Investigator
    STD FACULTY EXPANSION PROGRAM
    NIH R30PS921114Mar 1, 2002 - Feb 28, 2007
    Role: Principal Investigator
    AIDS CLINICAL TRIALS UNIT
    NIH U01AI027660Jun 30, 1986 - Dec 31, 2006
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Characterization of Treatment Resistance and Viral Kinetics in the Setting of Single-Active Versus Dual-Active Monoclonal Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2. J Infect Dis. 2024 Aug 16; 230(2):394-402. Choudhary MC, Deo R, Evering TH, Chew KW, Giganti MJ, Moser C, Ritz J, Regan J, Flynn JP, Crain CR, Wohl DA, Currier JS, Eron JJ, Margolis D, Zhu Q, Zhon L, Ya L, Greninger AL, Hughes MD, Smith D, Daar ES, Li JZ. PMID: 38716969; PMCID: PMC11326811.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    2. Comparison Study of the Bio-Plex and Meso Scale Multiplexed SARS-CoV-2 Serology Assays Reveals Evidence of Diminished Host Antibody Responses to SARS-CoV-2 after Monoclonal Antibody Treatment. Pathog Immun. 2024; 9(2):58-78. Parikh UM, Heaps AL, Moisi D, Gordon KC, Mellors JW, Choudhary MC, Deo R, Moser C, Klekotka P, Landay AL, Currier JS, Eron JJ, Chew KW, Smith DM, Li JZ, Sieg SF, Team ACTIV-2/A5401 Study. PMID: 39165724; PMCID: PMC11335343.
      View in: PubMed   Mentions:
    3. Willingness to trade-off years of life for an HIV cure - an experimental exploration of affective forecasting. AIDS Res Ther. 2024 Aug 06; 21(1):51. Fridman I, Eyal N, Scherr KA, Currier JS, Freedberg KA, Halpern SD, Kuritzkes DR, Magalhaes M, Pollak KI, Ubel PA. PMID: 39107832; PMCID: PMC11304558.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. SARS-CoV-2 monoclonal antibody treatment followed by vaccination shifts human memory B cell epitope recognition suggesting antibody feedback. J Infect Dis. 2024 Jul 22. Bloom N, Ramirez SI, Cohn H, Parikh UM, Heaps A, Sieg SF, Greninger A, Ritz J, Moser C, Eron JJ, Bajic G, Currier JS, Klekotka P, Wohl DA, Daar ES, Li J, Hughes MD, Chew KW, Smith DM, Crotty S, Coelho CH, Accelerating COVID-19 Therapeutic Interventions and Vaccines–2/A5401 (ACTIV-2/A5401) Study Team . PMID: 39036987.
      View in: PubMed   Mentions:    Fields:    
    5. Safety and Efficacy of SAB-185 for Non-hospitalized Adults with COVID-19: A Randomized Clinical Trial. J Infect Dis. 2024 Jul 20. Chew KW, Taiwo BO, Moser C, Daar ES, Wohl DA, Ritz J, Javan AC, Li JZ, Fischer W, Greninger AL, Bausch C, Luke T, Call R, Neytman G, Giganti MJ, Fletcher CV, Hughes MD, Eron JJ, Currier JS, Smith DM, ACTIV-2/A5401 Study Team . PMID: 39028902.
      View in: PubMed   Mentions:    Fields:    
    6. Severe Acute Respiratory Syndrome Coronavirus 2 Plasma Antibody and Nucleocapsid Antigen Status Predict Outcomes in Outpatients With Coronavirus Disease 2019. Clin Infect Dis. 2024 Jul 17. Jilg N, Giganti MJ, Chew KW, Shaw-Saliba K, Ritz J, Moser C, Evering TH, Daar ES, Eron JJ, Currier JS, Hughes MD, Lane HC, Dewar R, Smith DM, Li JZ. PMID: 39018444.
      View in: PubMed   Mentions:    Fields:    
    7. Weight Changes and Adverse Pregnancy Outcomes With Dolutegravir- and Tenofovir Alafenamide Fumarate-Containing Antiretroviral Treatment Regimens During Pregnancy and Postpartum. Clin Infect Dis. 2024 Jun 14; 78(6):1617-1628. Hoffman RM, Brummel S, Ziemba L, Chinula L, McCarthy K, Fairlie L, Jean-Philippe P, Chakhtoura N, Johnston B, Krotje C, Nematadzira TG, Nakayiwa F, Ndyanabangi V, Hanley S, Theron G, Violari A, João E, Correa MD, Hofer CB, Navanukroh O, Aurpibul L, Nevrekar N, Zash R, Shapiro R, Stringer JSA, Currier JS, Sax P, Lockman S, IMPAACT 2010/VESTED Study Team . PMID: 38180851; PMCID: PMC11175665.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    8. Early antiviral CD4 and CD8 T cell responses and antibodies are associated with upper respiratory tract clearance of SARS-CoV-2. bioRxiv. 2024 Jun 10. Ramirez SI, Lopez PG, Faraji F, Parikh UM, Heaps A, Ritz J, Moser C, Eron JJ, Wohl DA, Currier JS, Daar ES, Greninger AL, Klekotka P, Grifoni A, Weiskopf D, Sette A, Peters B, Hughes MD, Chew KW, Smith DM, Crotty S, ACTIV-2/A5401 Study Team. PMID: 37961119; PMCID: PMC10634820.
      View in: PubMed   Mentions:
    9. Response to Drs de Grooth and Parienti. J Infect Dis. 2024 May 15; 229(5):1596. Giganti MJ, Chew KW, Eron JJ, Smith DM, Currier JS, Hughes MD. PMID: 38324658.
      View in: PubMed   Mentions:    Fields:    
    10. Safety, Efficacy, and Pharmacokinetics of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies BMS-986414 (C135-LS) and BMS-986413 (C144-LS) Administered Subcutaneously in Non-Hospitalized Persons with COVID-19 in a Phase 2 Trial. Pathog Immun. 2024; 9(1):138-155. Corado KC, Chew KW, Giganti MJ, Mu Y, Fletcher CV, Currier JS, Daar ES, Wohl DA, Li JZ, Moser CB, Ritz J, Javan AC, Neytman G, Caskey M, Hughes MD, Smith DM, Eron JJ, ACTIV-2/A5401 Study Team. PMID: 38746756; PMCID: PMC11093219.
      View in: PubMed   Mentions:
    11. Coronary Plaque in People With HIV vs Non-HIV Asymptomatic Community and Symptomatic Higher-Risk Populations. JACC Adv. 2024 Jun; 3(6):100968. Karady J, Lu MT, Bergström G, Mayrhofer T, Taron J, Foldyna B, Paradis K, McCallum S, Aberg JA, Currier JS, Fitch KV, Fulda ES, Bloomfield GS, Overton ET, Lind L, Östgren CJ, Elvstam O, Söderberg S, Jernberg T, Pepe R, Dubé MP, Mushatt D, Fichtenbaum CJ, Malvestutto C, Zanni MV, Hoffmann U, Ribaudo H, Grinspoon SK, Douglas PS. PMID: 38938873; PMCID: PMC11198107.
      View in: PubMed   Mentions:
    12. Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibody. PLoS Pathog. 2024 Apr; 20(4):e1011680. Phan T, Zitzmann C, Chew KW, Smith DM, Daar ES, Wohl DA, Eron JJ, Currier JS, Hughes MD, Choudhary MC, Deo R, Li JZ, Ribeiro RM, Ke R, Perelson AS, ACTIV-2/A5401 Study Team. PMID: 38635853; PMCID: PMC11060554.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    13. Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV: Mechanistic Substudy of the REPRIEVE Randomized Clinical Trial. JAMA Cardiol. 2024 Apr 01; 9(4):323-334. Lu MT, Ribaudo H, Foldyna B, Zanni MV, Mayrhofer T, Karady J, Taron J, Fitch KV, McCallum S, Burdo TH, Paradis K, Hedgire SS, Meyersohn NM, DeFilippi C, Malvestutto CD, Sturniolo A, Diggs M, Siminski S, Bloomfield GS, Alston-Smith B, Desvigne-Nickens P, Overton ET, Currier JS, Aberg JA, Fichtenbaum CJ, Hoffmann U, Douglas PS, Grinspoon SK, REPRIEVE Trial Writing Group. PMID: 38381407; PMCID: PMC10882511.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    14. Systemic inflammation in pregnant women with HIV: relationship with HIV treatment regimen and preterm delivery. AIDS. 2024 07 01; 38(8):1111-1119. Shivakoti R, Giganti MJ, Lederman MM, Ketchum R, Brummel S, Moisi D, Dadabhai S, Moodley D, Violari A, Chinula L, Owor M, Gupta A, Currier JS, Taha TE, Fowler MG, PROMISE study team. PMID: 38411599; PMCID: PMC11139235.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    15. Outpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trial. JCI Insight. 2024 Mar 14; 9(8). Park HS, Yin A, Barranta C, Lee JS, Caputo CA, Sachithanandham J, Li M, Yoon S, Sitaras I, Jedlicka A, Eby Y, Ram M, Fernandez RE, Baker OR, Shenoy AG, Mosnaim GS, Fukuta Y, Patel B, Heath SL, Levine AC, Meisenberg BR, Spivak ES, Anjan S, Huaman MA, Blair JE, Currier JS, Paxton JH, Gerber JM, Petrini JR, Broderick PB, Rausch W, Cordisco ME, Hammel J, Greenblatt B, Cluzet VC, Cruser D, Oei K, Abinante M, Hammitt LL, Sutcliffe CG, Forthal DN, Zand MS, Cachay ER, Raval JS, Kassaye SG, Marshall CE, Yarava A, Lane K, McBee NA, Gawad AL, Karlen N, Singh A, Ford DE, Jabs DA, Appel LJ, Shade DM, Lau B, Ehrhardt S, Baksh SN, Shapiro JR, Ou J, Na YB, Knoll MD, Ornelas-Gatdula E, Arroyo-Curras N, Gniadek TJ, Caturegli P, Wu J, Ndahiro N, Betenbaugh MJ, Ziman A, Hanley DF, Casadevall A, Shoham S, Bloch EM, Gebo KA, Tobian AA, Laeyendecker O, Pekosz A, Klein SL, Sullivan DJ. PMID: 38483534; PMCID: PMC11141865.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    16. Outpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trial. medRxiv. 2023 Dec 15. Park HS, Yin A, Barranta C, Lee JS, Caputo CA, Sachithanandham J, Li M, Yoon S, Sitaras I, Jedlicka A, Eby Y, Ram M, Fernandez RE, Baker OR, Shenoy AG, Mosnaim GS, Fukuta Y, Patel B, Heath SL, Levine AC, Meisenberg BR, Spivak ES, Anjan S, Huaman MA, Blair JE, Currier JS, Paxton JH, Gerber JM, Petrini JR, Broderick PB, Rausch W, Cordisco ME, Hammel J, Greenblatt B, Cluzet VC, Cruser D, Oei K, Abinante M, Hammitt LL, Sutcliffe CG, Forthal DN, Zand MS, Cachay ER, Raval JS, Kassaye SG, Marshall CE, Yarava A, Lane K, McBee NA, Gawad AL, Karlen N, Singh A, Ford DE, Jabs DA, Appel LJ, Shade DM, Lau B, Ehrhardt S, Baksh SN, Shapiro JR, Ou J, Na YB, Knoll MD, Ornelas-Gatdula E, Arroyo-Curras N, Gniadek TJ, Caturegli P, Wu J, Ndahiro N, Betenbaugh MJ, Ziman A, Hanley DF, Casadevall A, Shoham S, Bloch EM, Gebo KA, Tobian AAR, Laeyendecker O, Pekosz A, Klein SL, Sullivan DJ. PMID: 37131659; PMCID: PMC10153328.
      View in: PubMed   Mentions:
    17. Pericoronary Adipose Tissue Density, Inflammation, and Subclinical Coronary Artery Disease Among People With HIV in the REPRIEVE Cohort. Clin Infect Dis. 2023 12 15; 77(12):1676-1686. Foldyna B, Mayrhofer T, Zanni MV, Lyass A, Barve R, Karady J, McCallum S, Burdo TH, Fitch KV, Paradis K, Fulda ES, Diggs MR, Bloomfield GS, Malvestutto CD, Fichtenbaum CJ, Aberg JA, Currier JS, Ribaudo HJ, Hoffmann U, Lu MT, Douglas PS, Grinspoon SK. PMID: 37439633; PMCID: PMC10724469.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    18. Erratum for Gebo et al., "Early antibody treatment, inflammation, and risk of post-COVID conditions". mBio. 2024 Jan 16; 15(1):e0297923. Gebo KA, Heath SL, Fukuta Y, Zhu X, Baksh S, Abraham AG, Habtehyimer F, Shade D, Ruff J, Ram M, Laeyendecker O, Fernandez RE, Patel EU, Baker OR, Shoham S, Cachay ER, Currier JS, Gerber JM, Meisenberg B, Forthal DN, Hammitt LL, Huaman MA, Levine A, Mosnaim GS, Patel B, Paxton JH, Raval JS, Sutcliffe CG, Anjan S, Gniadek T, Kassaye S, Blair JE, Lane K, McBee NA, Gawad AL, Das P, Klein SL, Pekosz A, Bloch EM, Hanley D, Casadevall A, Tobian AAR, Sullivan DJ, CSSC-004 Consortium. PMID: 38095433; PMCID: PMC10790766.
      View in: PubMed   Mentions:    Fields:    
    19. COVID-19 convalescent plasma therapy decreases inflammatory cytokines: a randomized controlled trial. Microbiol Spectr. 2024 Jan 11; 12(1):e0328623. Habtehyimer F, Zhu X, Redd AD, Gebo KA, Abraham AG, Patel EU, Laeyendecker O, Gniadek TJ, Fernandez RE, Baker OR, Ram M, Cachay ER, Currier JS, Fukuta Y, Gerber JM, Heath SL, Meisenberg B, Huaman MA, Levine AC, Shenoy A, Anjan S, Blair JE, Cruser D, Forthal DN, Hammitt LL, Kassaye S, Mosnaim GS, Patel B, Paxton JH, Raval JS, Sutcliffe CG, Abinante M, Oei KS, Cluzet V, Cordisco ME, Greenblatt B, Rausch W, Shade D, Gawad AL, Klein SL, Pekosz A, Shoham S, Casadevall A, Bloch EM, Hanley D, Tobian AAR, Sullivan DJ. PMID: 38009954; PMCID: PMC10783116.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    20. SARS-CoV-2 monoclonal antibody treatment followed by vaccination shifts human memory B cell epitope recognition suggesting antibody feedback. bioRxiv. 2023 Nov 22. Coelho CH, Bloom N, Ramirez SI, Parikh UM, Heaps A, Sieg SF, Greninger A, Ritz J, Moser C, Eron JJ, Currier JS, Klekotka P, Wohl DA, Daar ES, Li J, Hughes MD, Chew KW, Smith DM, Crotty S, Accelerating COVID-19 Therapeutic Interventions and Vaccines–2/A5401 (ACTIV-2/A5401) Study Team. PMID: 38045374; PMCID: PMC10690233.
      View in: PubMed   Mentions:
    21. Metabolomic profiling of preterm birth in pregnant women living with HIV. Metabolomics. 2023 10 25; 19(11):91. Tobin NH, Murphy A, Li F, Brummel SS, Fowler MG, Mcintyre JA, Currier JS, Chipato T, Flynn PM, Gadama LA, Saidi F, Nakabiito C, Koos BJ, Aldrovandi GM, IMPAACT 1077BF/1077FF PROMISE Study Team. PMID: 37880481; PMCID: PMC10600291.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    22. Hepatitis B virus clinical and virologic characteristics in an HIV perinatal transmission study in sub-Saharan Africa. AIDS. 2024 03 01; 38(3):329-337. Bhattacharya D, Guo R, Tseng CH, Emel L, Sun R, Zhang TH, Chiu SH, Stranix-Chibanda L, Chipato T, Ship H, Mohtashemi NZ, Kintu K, Manji KP, Moodley D, Maldonado Y, Currier JS, Thio CL. PMID: 37861675.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    23. Safety and efficacy of inhaled interferon-β1a (SNG001) in adults with mild-to-moderate COVID-19: a randomized, controlled, phase II trial. EClinicalMedicine. 2023 Nov; 65:102250. Jagannathan P, Chew KW, Giganti MJ, Hughes MD, Moser C, Main MJ, Monk PD, Javan AC, Li JZ, Fletcher CV, McCarthy C, Wohl DA, Daar ES, Eron JJ, Currier JS, Singh U, Smith DM, Fischer W, ACTIV-2/A5401 Study Team. PMID: 37855026; PMCID: PMC10579289.
      View in: PubMed   Mentions: 2  
    24. One Week of Oral Camostat Versus Placebo in Nonhospitalized Adults With Mild-to-Moderate Coronavirus Disease 2019: A Randomized Controlled Phase 2 Trial. Clin Infect Dis. 2023 10 05; 77(7):941-949. Jilg N, Chew KW, Giganti MJ, Daar ES, Wohl DA, Javan AC, Kantor A, Moser C, Coombs RW, Neytman G, Hoover K, Jana A, Hart PA, Greninger AL, Szurgot B, Eron JJ, Currier JS, Hughes MD, Smith DM, Li JZ, ACTIV-2/A5401 Study Team. PMID: 37279602; PMCID: PMC10552586.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCellsCTClinical Trials
    25. Early antibody treatment, inflammation, and risk of post-COVID conditions. mBio. 2023 Oct 31; 14(5):e0061823. Gebo KA, Heath SL, Fukuta Y, Zhu X, Baksh S, Abraham AG, Habtehyimer F, Shade D, Ruff J, Ram M, Laeyendecker O, Fernandez RE, Patel EU, Baker OR, Shoham S, Cachay ER, Currier JS, Gerber JM, Meisenberg B, Forthal DN, Hammitt LL, Huaman MA, Levine A, Mosnaim GS, Patel B, Paxton JH, Raval JS, Sutcliffe CG, Anjan S, Gniadek T, Kassaye S, Blair JE, Lane K, McBee NA, Gawad AL, Das P, Klein SL, Pekosz A, Bloch EM, Hanley D, Casadevall A, Tobian AAR, Sullivan DJ, CSSC-004 Consortium. PMID: 37724870; PMCID: PMC10653913.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    26. Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibody. bioRxiv. 2023 Sep 17. Phan T, Zitzmann C, Chew KW, Smith DM, Daar ES, Wohl DA, Eron JJ, Currier JS, Hughes MD, Choudhary MC, Deo R, Li JZ, Ribeiro RM, Ke R, Perelson AS, ACTIV-2/A5401 Study Team. PMID: 37745410; PMCID: PMC10515893.
      View in: PubMed   Mentions:
    27. Biological and Clinical Implications of the Vascular Endothelial Growth Factor Coreceptor Neuropilin-1 in Human Immunodeficiency Virus. Open Forum Infect Dis. 2023 Oct; 10(10):ofad467. Schnittman SR, Kolossváry M, Beck-Engeser G, Fitch KV, Ambayec GC, Nance RM, Zanni MV, Diggs M, Chan F, McCallum S, Toribio M, Bamford L, Fichtenbaum CJ, Eron JJ, Jacobson JM, Mayer KH, Malvestutto C, Bloomfield GS, Moore RD, Umbleja T, Saag MS, Aberg JA, Currier JS, Delaney JAC, Martin JN, Lu MT, Douglas PS, Ribaudo HJ, Crane HM, Hunt PW, Grinspoon SK. PMID: 37869406; PMCID: PMC10590105.
      View in: PubMed   Mentions:
    28. Variant-Specific Viral Kinetics in Acute COVID-19. J Infect Dis. 2023 08 31; 228(Suppl 2):S136-S143. Ribeiro RM, Choudhary MC, Deo R, Giganti MJ, Moser C, Ritz J, Greninger AL, Regan J, Flynn JP, Wohl DA, Currier JS, Eron JJ, Hughes MD, Smith DM, Chew KW, Daar ES, Perelson AS, Li JZ, ACTIV-2/A5401 Study Team. PMID: 37650233; PMCID: PMC10469346.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsCTClinical Trials
    29. ACTIV-2: A Platform Trial for the Evaluation of Novel Therapeutics for the Treatment of Early COVID-19 in Outpatients. J Infect Dis. 2023 08 31; 228(Suppl 2):S77-S82. Currier JS, Moser C, Eron JJ, Chew KW, Smith DM, Javan AC, Wohl DA, Daar ES, Hughes MD, ACTIV-2/A5401 Study Team. PMID: 37650231; PMCID: PMC10469341.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    30. Pooling Different Placebos as a Control Group in a Randomized Platform Trial: Benefits and Challenges From Experience in the ACTIV-2 COVID-19 Trial. J Infect Dis. 2023 08 31; 228(Suppl 2):S92-S100. Moser CB, Chew KW, Ritz J, Newell M, Javan AC, Eron JJ, Daar ES, Wohl DA, Currier JS, Smith DM, Hughes MD, ACTIV-2/A5401 Study Team. PMID: 37650234; PMCID: PMC10686688.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    31. Long COVID After Bamlanivimab Treatment. J Infect Dis. 2023 08 31; 228(Suppl 2):S126-S135. Evering TH, Moser CB, Jilg N, Yeh E, Sanusi B, Wohl DA, Daar ES, Li JZ, Klekotka P, Javan AC, Eron JJ, Currier JS, Hughes MD, Smith DM, Chew KW, ACTIV-2/A5401 Study Team. PMID: 37650236; PMCID: PMC10686694.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    32. Immune Status and SARS-CoV-2 Viral Dynamics. J Infect Dis. 2023 08 31; 228(Suppl 2):S111-S116. Li Y, Moser C, Aga E, Currier JS, Wohl DA, Daar ES, Ritz J, Greninger AL, Sieg S, Parikh UM, Coombs RW, Hughes MD, Eron JJ, Smith DM, Chew KW, Li JZ, ACTIV-2/A5401 Study Team. PMID: 37650232; PMCID: PMC10469582.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsCTClinical Trials
    33. Association Between Anterior Nasal and Plasma SARS-CoV-2 RNA Levels and Hospitalization or Death in Nonhospitalized Adults With Mild-to-Moderate COVID-19. J Infect Dis. 2023 08 31; 228(Suppl 2):S117-S125. Giganti MJ, Chew KW, Eron JJ, Li JZ, Pinilla M, Moser C, Javan AC, Fischer WA, Klekotka P, Margolis D, Wohl DA, Coombs RW, Daar ES, Smith DM, Currier JS, Hughes MD, ACTIV-2/A5401 Study Team. PMID: 37650230; PMCID: PMC10469105.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsCTClinical Trials
    34. Statistical Challenges When Analyzing SARS-CoV-2 RNA Measurements Below the Assay Limit of Quantification in COVID-19 Clinical Trials. J Infect Dis. 2023 08 31; 228(Suppl 2):S101-S110. Moser CB, Chew KW, Giganti MJ, Li JZ, Aga E, Ritz J, Greninger AL, Javan AC, Bender Ignacio R, Daar ES, Wohl DA, Currier JS, Eron JJ, Smith DM, Hughes MD, ACTIV-2/A5401 Study Team. PMID: 37650235; PMCID: PMC10469328.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCellsCTClinical Trials
    35. Validity and Characterization of Time to Symptom Resolution Outcome Measures in the ACTIV-2/A5401 Outpatient COVID-19 Treatment Trial. J Infect Dis. 2023 08 31; 228(Suppl 2):S83-S91. Chew KW, Moser C, Yeh E, Wohl DA, Daar ES, Ritz J, Javan AC, Eron JJ, Currier JS, Smith DM, Hughes MD, ACTIV-2/A5401 Study Team. PMID: 37650237; PMCID: PMC10469584.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    36. Realising long-acting ART as first-line treatment. Lancet HIV. 2023 09; 10(9):e558-e559. Vijayan T, Currier JS. PMID: 37567204.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    37. Dynamics of inflammatory responses after SARS-CoV-2 infection by vaccination status in the USA: a prospective cohort study. Lancet Microbe. 2023 09; 4(9):e692-e703. Zhu X, Gebo KA, Abraham AG, Habtehyimer F, Patel EU, Laeyendecker O, Gniadek TJ, Fernandez RE, Baker OR, Ram M, Cachay ER, Currier JS, Fukuta Y, Gerber JM, Heath SL, Meisenberg B, Huaman MA, Levine AC, Shenoy A, Anjan S, Blair JE, Cruser D, Forthal DN, Hammitt LL, Kassaye S, Mosnaim GS, Patel B, Paxton JH, Raval JS, Sutcliffe CG, Abinante M, Broderick P, Cluzet V, Cordisco ME, Greenblatt B, Petrini J, Rausch W, Shade D, Lane K, Gawad AL, Klein SL, Pekosz A, Shoham S, Casadevall A, Bloch EM, Hanley D, Sullivan DJ, Tobian AAR. PMID: 37659419; PMCID: PMC10475695.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    38. Transfusion reactions associated with COVID-19 convalescent plasma in outpatient clinical trials. Transfusion. 2023 09; 63(9):1639-1648. Huaman MA, Raval JS, Paxton JH, Mosnaim GS, Patel B, Anjan S, Meisenberg BR, Levine AC, Marshall CE, Yarava A, Shenoy AG, Heath SL, Currier JS, Fukuta Y, Blair JE, Spivak ES, Petrini JR, Broderick PB, Rausch W, Cordisco M, Hammel J, Greenblatt B, Cluzet VC, Cruser D, Oei K, Abinante M, Hammitt LL, Sutcliffe CG, Forthal DN, Zand MS, Cachay ER, Kassaye SG, Ram M, Wang Y, Das P, Lane K, McBee NA, Gawad AL, Karlen N, Ford DE, Laeyendecker O, Pekosz A, Klein SL, Ehrhardt S, Lau B, Baksh SN, Shade DM, Casadevall A, Hanley DF, Ou J, Gniadek TJ, Ziman A, Shoham S, Gebo KA, Bloch EM, Tobian AAR, Sullivan DJ, Gerber JM. PMID: 37534607; PMCID: PMC10720768.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    39. Comparison of Antiretroviral Therapies in Pregnant Women Living With Human Immunodeficiency Virus and Hepatitis B Virus: A Randomized Controlled Trial. Obstet Gynecol. 2023 09 01; 142(3):613-624. Bhattacharya D, Tierney C, Butler K, Kiweewa FM, Moodley D, Govender V, Vhembo T, Mohtashemi N, Ship H, Dula D, George K, Chaktoura N, Fowler MG, Peters MG, Currier JS. PMID: 37535953; PMCID: PMC10527604.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsPHPublic Health
    40. Pitavastatin to Prevent Cardiovascular Disease in HIV Infection. N Engl J Med. 2023 Aug 24; 389(8):687-699. Grinspoon SK, Fitch KV, Zanni MV, Fichtenbaum CJ, Umbleja T, Aberg JA, Overton ET, Malvestutto CD, Bloomfield GS, Currier JS, Martinez E, Roa JC, Diggs MR, Fulda ES, Paradis K, Wiviott SD, Foldyna B, Looby SE, Desvigne-Nickens P, Alston-Smith B, Leon-Cruz J, McCallum S, Hoffmann U, Lu MT, Ribaudo HJ, Douglas PS, REPRIEVE Investigators. PMID: 37486775; PMCID: PMC10564556.
      View in: PubMed   Mentions: 55     Fields:    Translation:HumansCTClinical Trials
    41. Phase 2 Safety and Antiviral Activity of SAB-185, a Novel Polyclonal Antibody Therapy for Nonhospitalized Adults With COVID-19. J Infect Dis. 2023 07 14; 228(2):133-142. Taiwo BO, Chew KW, Moser C, Wohl DA, Daar ES, Li JZ, Greninger AL, Bausch C, Luke T, Hoover K, Neytman G, Giganti MJ, Olefsky M, Javan AC, Fletcher CV, Eron JJ, Currier JS, Hughes MD, Smith DM, ACTIV-2/A5401 Study Team. PMID: 36661240; PMCID: PMC10345463.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCellsCTClinical Trials
    42. Symptom Duration and Resolution With Early Outpatient Treatment of Convalescent Plasma for Coronavirus Disease 2019: A Randomized Trial. J Infect Dis. 2023 05 29; 227(11):1266-1273. Baksh SN, Heath SL, Fukuta Y, Shade D, Meisenberg B, Bloch EM, Tobian AAR, Spivak ES, Patel B, Gerber J, Raval JS, Forthal D, Paxton J, Mosnaim G, Anjan S, Blair J, Cachay E, Currier J, Das P, Huaman M, Sutcliffe C, Yarava A, Casadevall A, Sullivan D, Hanley D, Gebo KA. PMID: 36722044; PMCID: PMC10226658.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    43. Efficacy and safety of three antiretroviral therapy regimens started in pregnancy up to 50 weeks post partum: a multicentre, open-label, randomised, controlled, phase 3 trial. Lancet HIV. 2023 06; 10(6):e363-e374. Chinula L, Ziemba L, Brummel S, McCarthy K, Coletti A, Krotje C, Johnston B, Knowles K, Moyo S, Stranix-Chibanda L, Hoffman R, Sax PE, Stringer J, Chakhtoura N, Jean-Philippe P, Korutaro V, Cassim H, Fairlie L, Masheto G, Boyce C, Frenkel LM, Amico KR, Purdue L, Shapiro R, Mmbaga BT, Patel F, van Wyk J, Rooney JF, Currier JS, Lockman S, IMPAACT 2010/VESTED Study Team and Investigators. PMID: 37167996; PMCID: PMC10280394.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    44. Safety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19. Ann Intern Med. 2023 05; 176(5):658-666. Evering TH, Chew KW, Giganti MJ, Moser C, Pinilla M, Wohl DA, Currier JS, Eron JJ, Javan AC, Bender Ignacio R, Margolis D, Zhu Q, Ma J, Zhong L, Yan L, D'Andrea Nores U, Hoover K, Mocherla B, Choudhary MC, Deo R, Ritz J, Fischer WA, Fletcher CV, Li JZ, Hughes MD, Smith D, Daar ES, ACTIV-2/A5401 Study Team. PMID: 37068272; PMCID: PMC10150320.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    45. The importance of appropriate selection of clinical endpoints in outpatient COVID-19 clinical trials. Commun Med (Lond). 2023 Apr 17; 3(1):53. Thorlund K, Smith D, Linsell C, White N, Butler C, Boulware D, Currier J, Harari O, Lhomme E, Strub-Wourgaft N, Adam S, Mills E. PMID: 37069219; PMCID: PMC10107578.
      View in: PubMed   Mentions:
    46. Safety and Efficacy of Combined Tixagevimab and Cilgavimab Administered Intramuscularly or Intravenously in Nonhospitalized Patients With COVID-19: 2 Randomized Clinical Trials. JAMA Netw Open. 2023 04 03; 6(4):e2310039. Bender Ignacio RA, Chew KW, Moser C, Currier JS, Eron JJ, Javan AC, Giganti MJ, Aga E, Gibbs M, Tchouakam Kouekam H, Johnsson E, Esser MT, Hoover K, Neytman G, Newell M, Daar ES, Fischer W, Fletcher CV, Li JZ, Greninger AL, Coombs RW, Hughes MD, Smith D, Wohl DA, Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)–2/A5401 Study Team. PMID: 37099295; PMCID: PMC10134004.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    47. Identification of pre-infection markers and differential plasma protein expression following SARS-CoV-2 infection in people living with HIV. EBioMedicine. 2023 Apr; 90:104538. Kolossváry M, deFilippi C, McCallum S, Fitch KV, Diggs MR, Fulda ES, Ribaudo HJ, Fichtenbaum CJ, Aberg JA, Malvestutto CD, Currier JS, Casado JL, Gutiérrez F, Sereti I, Douglas PS, Zanni MV, Grinspoon SK. PMID: 36966617; PMCID: PMC10037041.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsPHPublic Health
    48. Statistical Challenges when Analyzing SARS-CoV-2 RNA Measurements Below the Assay Limit of Quantification in COVID-19 Clinical Trials. medRxiv. 2023 Mar 17. Moser CB, Chew KW, Giganti MJ, Li JZ, Aga E, Ritz J, Greninger AL, Javan AC, Daar ES, Currier JS, Eron JJ, Smith DM, Hughes MD. PMID: 36993419; PMCID: PMC10055451.
      View in: PubMed   Mentions:
    49. Effect of host factors and COVID-19 infection on the humoral immune repertoire in treated HIV. JCI Insight. 2023 03 08; 8(5). Schnittman SR, Jung W, Fitch KV, Zanni MV, McCallum S, Lee JS, Shin S, Davis BJ, Fulda ES, Diggs MR, Giguel F, Chinchay R, Sheth AN, Fichtenbaum CJ, Malvestutto C, Aberg JA, Currier J, Lauffenburger DA, Douglas PS, Ribaudo HJ, Alter G, Grinspoon SK. PMID: 36805331; PMCID: PMC10077482.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    50. Coronary Artery Plaque Composition and Severity Relate to the Inflammasome in People With Treated Human Immunodeficiency Virus. Open Forum Infect Dis. 2023 Mar; 10(3):ofad106. Schnittman SR, Kitch DW, Swartz TH, Burdo TH, Fitch KV, McCallum S, Flynn JM, Fulda ES, Diggs MR, Stapleton JT, Casado JL, Taron J, Currier JS, Zanni MV, Malvestutto C, Fichtenbaum CJ, Aberg JA, Ribaudo HJ, Lu MT, Douglas PS, Grinspoon SK. PMID: 36998633; PMCID: PMC10043127.
      View in: PubMed   Mentions: 1  
    51. Symptom and Viral Rebound in Untreated SARS-CoV-2 Infection. Ann Intern Med. 2023 03; 176(3):348-354. Deo R, Choudhary MC, Moser C, Ritz J, Daar ES, Wohl DA, Greninger AL, Eron JJ, Currier JS, Hughes MD, Smith DM, Chew KW, Li JZ, ACTIV-2/A5401 Study Team. PMID: 36802755; PMCID: PMC10052317.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    52. Early Treatment, Inflammation and Post-COVID Conditions. medRxiv. 2023 Feb 16. Gebo KA, Heath SL, Fukuta Y, Zhu X, Baksh S, Abraham AG, Habtehyimer F, Shade D, Ruff J, Ram M, Laeyendecker O, Fernandez RE, Patel EU, Baker OR, Shoham S, Cachay ER, Currier JS, Gerber JM, Meisenberg B, Forthal DN, Hammitt LL, Huaman MA, Levine A, Mosnaim GS, Patel B, Paxton JH, Raval JS, Sutcliffe CG, Anjan S, Gniadek T, Kassaye S, Blair JE, Lane K, McBee NA, Gawad AL, Das P, Klein SL, Pekosz A, Casadevall A, Bloch EM, Hanley D, Tobian AAR, Sullivan DJ. PMID: 36824860; PMCID: PMC9949202.
      View in: PubMed   Mentions:
    53. Experiences with telemedicine for HIV care in two federally qualified health centers in Los Angeles: a qualitative study. BMC Health Serv Res. 2023 Feb 15; 23(1):156. Walker D, Moucheraud C, Butler D, de Vente J, Tangonan K, Shoptaw S, Currier JS, Gladstein J, Hoffman R. PMID: 36793080; PMCID: PMC9930012.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    54. Cytomegalovirus Immunoglobulin G (IgG) Titer and Coronary Artery Disease in People With Human Immunodeficiency Virus (HIV). Clin Infect Dis. 2023 02 08; 76(3):e613-e621. Schnittman SR, Lu MT, Mayrhofer T, Burdo TH, Fitch KV, McCallum S, Fulda ES, Zanni MV, Foldyna B, Malvestutto C, Fichtenbaum CJ, Aberg JA, Bloomfield GS, Overton ET, Currier J, Tebas P, Sha BE, Ribaudo HJ, Flynn JM, Douglas PS, Erlandson KM, Grinspoon SK. PMID: 35975297; PMCID: PMC10169419.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    55. Transfusing Convalescent Plasma as Post-Exposure Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Double-Blinded, Phase 2 Randomized, Controlled Trial. Clin Infect Dis. 2023 02 08; 76(3):e477-e486. Shoham S, Bloch EM, Casadevall A, Hanley D, Lau B, Gebo K, Cachay E, Kassaye SG, Paxton JH, Gerber J, Levine AC, Naeim A, Currier J, Patel B, Allen ES, Anjan S, Appel L, Baksh S, Blair PW, Bowen A, Broderick P, Caputo CA, Cluzet V, Cordisco ME, Cruser D, Ehrhardt S, Forthal D, Fukuta Y, Gawad AL, Gniadek T, Hammel J, Huaman MA, Jabs DA, Jedlicka A, Karlen N, Klein S, Laeyendecker O, Lane K, McBee N, Meisenberg B, Merlo C, Mosnaim G, Park HS, Pekosz A, Petrini J, Rausch W, Shade DM, Shapiro JR, Singleton JR, Sutcliffe C, Thomas DL, Yarava A, Zand M, Zenilman JM, Tobian AAR, Sullivan DJ. PMID: 35579509; PMCID: PMC9129191.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCellsCTClinical Trials
    56. Hydroxychloroquine for pre-exposure prophylaxis of COVID-19 in health care workers: a randomized, multicenter, placebo-controlled trial Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine (HERO-HCQ). Int J Infect Dis. 2023 Apr; 129:40-48. Naggie S, Milstone A, Castro M, Collins SP, Lakshmi S, Anderson DJ, Cahuayme-Zuniga L, Turner KB, Cohen LW, Currier J, Fraulo E, Friedland A, Garg J, George A, Mulder H, Olson RE, O'Brien EC, Rothman RL, Shenkman E, Shostak J, Woods CW, Anstrom KJ, Hernandez AF, HERO Research Program. PMID: 36682681; PMCID: PMC9851717.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCellsPHPublic Health
    57. Publisher Correction: Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19. Nat Commun. 2023 Jan 19; 14(1):333. Chew KW, Moser C, Daar ES, Wohl DA, Li JZ, Coombs RW, Ritz J, Giganti M, Javan AC, Li Y, Choudhary MC, Deo R, Malvestutto C, Klekotka P, Price K, Nirula A, Fischer W, Bala V, Ribeiro RM, Perelson AS, Fletcher CV, Eron JJ, Currier JS, ACTIV-2/A5401 Study Team, Hughes MD, Smith DM. PMID: 36658128; PMCID: PMC9851732.
      View in: PubMed   Mentions:    Fields:    
    58. Sex Differences in Subclinical Atherosclerosis and Systemic Immune Activation/Inflammation Among People With Human Immunodeficiency Virus in the United States. Clin Infect Dis. 2023 01 13; 76(2):323-334. Zanni MV, Foldyna B, McCallum S, Burdo TH, Looby SE, Fitch KV, Fulda ES, Autissier P, Bloomfield GS, Malvestutto CD, Fichtenbaum CJ, Overton ET, Aberg JA, Erlandson KM, Campbell TB, Ellsworth GB, Sheth AN, Taiwo B, Currier JS, Hoffmann U, Lu MT, Douglas PS, Ribaudo HJ, Grinspoon SK. PMID: 36101518; PMCID: PMC9839188.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    59. Bamlanivimab therapy for acute COVID-19 does not blunt SARS-CoV-2-specific memory T cell responses. JCI Insight. 2022 12 22; 7(24). Ramirez SI, Grifoni A, Weiskopf D, Parikh UM, Heaps A, Faraji F, Sieg SF, Ritz J, Moser C, Eron JJ, Currier JS, Klekotka P, Sette A, Wohl DA, Daar ES, Hughes MD, Chew KW, Smith DM, Crotty S, Accelerating COVID-19 Therapeutic Interventions and Vaccines–2/A5401 (ACTIV-2/A5401) Study Team. PMID: 36378539; PMCID: PMC9869965.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    60. Proteomic Signature of Subclinical Coronary Artery Disease in People With HIV: Analysis of the REPRIEVE Mechanistic Substudy. J Infect Dis. 2022 11 11; 226(10):1809-1822. Kolossváry M, deFilippi C, Lu MT, Zanni MV, Fulda ES, Foldyna B, Ribaudo H, Mayrhofer T, Collier AC, Bloomfield GS, Fichtenbaum C, Overton ET, Aberg JA, Currier J, Fitch KV, Douglas PS, Grinspoon SK. PMID: 35535576; PMCID: PMC10205625.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    61. Predictors of SARS-CoV-2 RNA From Nasopharyngeal Swabs and Concordance With Other Compartments in Nonhospitalized Adults With Mild to Moderate COVID-19. Open Forum Infect Dis. 2022 Nov; 9(11):ofac618. Moser C, Li JZ, Eron JJ, Aga E, Daar ES, Wohl DA, Coombs RW, Javan AC, Bender Ignacio RA, Jagannathan P, Ritz J, Sieg SF, Parikh UM, Hughes MD, Currier JS, Smith DM, Chew KW, ACTIV-2/A5401 Study Team . PMID: 36467293; PMCID: PMC9709705.
      View in: PubMed   Mentions: 7  
    62. Emergence of SARS-CoV-2 escape mutations during Bamlanivimab therapy in a phase II randomized clinical trial. Nat Microbiol. 2022 11; 7(11):1906-1917. Choudhary MC, Chew KW, Deo R, Flynn JP, Regan J, Crain CR, Moser C, Hughes MD, Ritz J, Ribeiro RM, Ke R, Dragavon JA, Javan AC, Nirula A, Klekotka P, Greninger AL, Fletcher CV, Daar ES, Wohl DA, Eron JJ, Currier JS, Parikh UM, Sieg SF, Perelson AS, Coombs RW, Smith DM, Li JZ, ACTIV-2/A5401 Study Team. PMID: 36289399; PMCID: PMC9675946.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCellsCTClinical Trials
    63. Prevalence and Factors Associated With Antigen Test Positivity Following SARS-CoV-2 Infection Among Health Care Workers in Los Angeles. Open Forum Infect Dis. 2022 Oct; 9(10):ofac462. Adamson PC, Currier JS, Uslan DZ, Garner OB. PMID: 36285175; PMCID: PMC9581505.
      View in: PubMed   Mentions: 1  
    64. Factors Associated With Systemic Immune Activation Indices in a Global Primary Cardiovascular Disease Prevention Cohort of People With Human Immunodeficiency Virus on Antiretroviral Therapy. Clin Infect Dis. 2022 10 12; 75(8):1324-1333. Looby SE, Kantor A, Burdo TH, Currier JS, Fichtenbaum CJ, Overton ET, Aberg JA, Malvestutto CD, Bloomfield GS, Erlandson KM, Cespedes M, Kallas EG, Masiá M, Thornton AC, Smith MD, Flynn JM, Kileel EM, Fulda E, Fitch KV, Lu MT, Douglas PS, Grinspoon SK, Ribaudo HJ, Zanni MV. PMID: 35235653; PMCID: PMC9555837.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    65. Recurrence of Symptoms Following a 2-Day Symptom Free Period in Patients With COVID-19. JAMA Netw Open. 2022 10 03; 5(10):e2238867. Smith DM, Li JZ, Moser C, Yeh E, Currier JS, Chew KW, Hughes MD, ACTIV-2/A5401 Study Team. PMID: 36301549; PMCID: PMC9614575.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    66. Self-reported Antiretroviral Adherence: Association With Maternal Viral Load Suppression in Postpartum Women Living With HIV-1 From Promoting Maternal and Infant Survival Everywhere, a Randomized Controlled Trial in Sub-Saharan Africa and India. J Acquir Immune Defic Syndr. 2023 01 01; 92(1):76-83. Nevrekar N, Butler K, Shapiro DE, Atuhaire P, Taha TE, Makanani B, Chinula L, Owor M, Moodley D, Chipato T, McCarthy K, Flynn PM, Currier J, Fowler MG, Gupta A, Suryavanshi N. PMID: 36170749; PMCID: PMC9722360.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    67. Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19. Nat Commun. 2022 08 22; 13(1):4931. Chew KW, Moser C, Daar ES, Wohl DA, Li JZ, Coombs RW, Ritz J, Giganti M, Javan AC, Li Y, Choudhary MC, Deo R, Malvestutto C, Klekotka P, Price K, Nirula A, Fischer W, Bala V, Ribeiro RM, Perelson AS, Fletcher CV, Eron JJ, Currier JS, ACTIV-2/A5401 Study Team, Hughes MD, Smith DM. PMID: 35995785; PMCID: PMC9395368.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    68. Trans women have worse cardiovascular biomarker profiles than cisgender men independent of hormone use and HIV serostatus. AIDS. 2022 11 01; 36(13):1801-1809. Lake JE, Wang R, Barrett BW, Bowman E, Hyatt AN, Debroy P, Candelario J, Teplin L, Bodnar K, McKay H, Plankey M, Brown TT, Funderburg N, Currier JS. PMID: 35950945; PMCID: PMC9529791.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    69. Viral and Symptom Rebound in Untreated COVID-19 Infection. medRxiv. 2022 Aug 02. Deo R, Choudhary MC, Moser C, Ritz J, Daar ES, Wohl DA, Greninger AL, Eron JJ, Currier JS, Hughes MD, Smith DM, Chew KW, Li JZ, ACTIV-2/A5401 Study Team. PMID: 35982660; PMCID: PMC9387151.
      View in: PubMed   Mentions: 1  
    70. Methotrexate Inhibits T Cell Proliferation but Not Inflammatory Cytokine Expression to Modulate Immunity in People Living With HIV. Front Immunol. 2022; 13:924718. Freeman ML, Clagett BM, Moisi D, Yeh E, Morris CD, Ryu A, Rodriguez B, Stein JH, Deeks SG, Currier JS, Hsue PY, Anthony DD, Calabrese LH, Ribaudo HJ, Lederman MM. PMID: 35967371; PMCID: PMC9374564.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    71. Audio Interview: Reinventing the Research Infrastructure to Address Covid-19. N Engl J Med. 2022 07 28; 387(4):e13. Rubin EJ, Baden LR, Currier JS, Morrissey S. PMID: 35939585.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    72. Comparative Pharmacokinetics of Tixagevimab/Cilgavimab (AZD7442) Administered Intravenously Versus Intramuscularly in Symptomatic SARS-CoV-2 Infection. Clin Pharmacol Ther. 2022 12; 112(6):1207-1213. Bender Ignacio RA, Wohl DA, Arends R, Pilla Reddy V, Mu Y, Javan AC, Hughes MD, Eron JJ, Currier JS, Smith D, Chew KW, Gibbs M, Fletcher CV. PMID: 35797235; PMCID: PMC9349574.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    73. Monoclonal antibody treatment drives rapid culture conversion in SARS-CoV-2 infection. Cell Rep Med. 2022 07 19; 3(7):100678. Boucau J, Chew KW, Choudhary MC, Deo R, Regan J, Flynn JP, Crain CR, Hughes MD, Ritz J, Moser C, Dragavon JA, Javan AC, Nirula A, Klekotka P, Greninger AL, Coombs RW, Fischer WA, Daar ES, Wohl DA, Eron JJ, Currier JS, Smith DM, POSITIVES study team, Li JZ, Barczak AK, ACTIV-2/A5401 Study Team. PMID: 35793677; PMCID: PMC9213028.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCellsCTClinical Trials
    74. Brief Report: Impact of Antiretroviral Regimen on Pregnancy and Infant Outcomes in Women With HIV/ HBV Coinfection. J Acquir Immune Defic Syndr. 2022 09 01; 91(1):79-84. Kiweewa FM, Tierney C, Butler K, Peters MG, Vhembo T, Moodley D, Govender V, Mohtashemi N, Ship H, Musoke P, Dula D, George K, Chakhtoura N, Fowler MG, Currier JS, Bhattacharya D. PMID: 35621877; PMCID: PMC9377493.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    75. High rate of left ventricular hypertrophy on screening echocardiography among adults living with HIV in Malawi. Open Heart. 2022 05; 9(1). Hoffman RM, Chibwana F, Banda BA, Kahn D, Gama K, Boas ZP, Chimombo M, Kussen C, Currier JS, Namarika D, van Oosterhout J, Phiri S, Moses A, Currier JW, Sigauke H, Moucheraud C, Canan T. PMID: 35649574; PMCID: PMC9161066.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    76. Early Outpatient Treatment for Covid-19 with Convalescent Plasma. N Engl J Med. 2022 05 05; 386(18):1700-1711. Sullivan DJ, Gebo KA, Shoham S, Bloch EM, Lau B, Shenoy AG, Mosnaim GS, Gniadek TJ, Fukuta Y, Patel B, Heath SL, Levine AC, Meisenberg BR, Spivak ES, Anjan S, Huaman MA, Blair JE, Currier JS, Paxton JH, Gerber JM, Petrini JR, Broderick PB, Rausch W, Cordisco ME, Hammel J, Greenblatt B, Cluzet VC, Cruser D, Oei K, Abinante M, Hammitt LL, Sutcliffe CG, Forthal DN, Zand MS, Cachay ER, Raval JS, Kassaye SG, Foster EC, Roth M, Marshall CE, Yarava A, Lane K, McBee NA, Gawad AL, Karlen N, Singh A, Ford DE, Jabs DA, Appel LJ, Shade DM, Ehrhardt S, Baksh SN, Laeyendecker O, Pekosz A, Klein SL, Casadevall A, Tobian AAR, Hanley DF. PMID: 35353960; PMCID: PMC9006786.
      View in: PubMed   Mentions: 119     Fields:    Translation:Humans
    77. Adipokines, Weight Gain and Metabolic and Inflammatory Markers After Antiretroviral Therapy Initiation: AIDS Clinical Trials Group (ACTG) A5260s. Clin Infect Dis. 2022 03 09; 74(5):857-864. Koethe JR, Moser C, Brown TT, Stein JH, Kelesidis T, Dube M, Currier J, McComsey GA. PMID: 34117756; PMCID: PMC8906713.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    78. Grayscale Ultrasound Texture Features of Carotid and Brachial Arteries in People With HIV Infection Before and After Antiretroviral Therapy. J Am Heart Assoc. 2022 03; 11(5):e024142. Hughey CM, Vuong BW, Ribaudo HB, Mitchell CCK, Korcarz CE, Hodis HN, Currier JS, Stein JH. PMID: 35179037; PMCID: PMC9075086.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    79. COVID-19 Vaccination Rates in a Global HIV Cohort. J Infect Dis. 2022 02 15; 225(4):603-607. Fulda ES, Fitch KV, Overton ET, Zanni MV, Aberg JA, Currier JS, Lu MT, Malvestutto C, Fichtenbaum CJ, Martinez E, Umbleja T, Douglas PS, Ribaudo HJ, Grinspoon SK. PMID: 34794178; PMCID: PMC8844595.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansPHPublic Health
    80. Distinct Lipidomic Signatures in People Living With HIV: Combined Analysis of ACTG 5260s and MACS/WIHS. J Clin Endocrinol Metab. 2022 01 01; 107(1):119-135. Jao J, Balmert LC, Sun S, McComsey GA, Brown TT, Tien PC, Currier JS, Stein JH, Qiu Y, LeRoith D, Kurland IJ. PMID: 34498048; PMCID: PMC8684537.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    81. Monoclonal antibody treatment drives rapid culture conversion in SARS-CoV-2 infection. medRxiv. 2021 Dec 30. Boucau J, Chew KW, Choudhary M, Deo R, Regan J, Flynn JP, Crain CR, Hughes MD, Ritz J, Moser C, Dragavon JA, Javan AC, Nirula A, Klekotka P, Greninger AL, Coombs RW, Fischer WA, Daar ES, Wohl DA, Eron JJ, Currier JS, Smith DM, Li JZ, Barczak AK, ACTIV-2/A5401 Study Team. PMID: 35018382; PMCID: PMC8750705.
      View in: PubMed   Mentions: 3  
    82. Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent Plasma. medRxiv. 2021 Dec 21. Sullivan DJ, Gebo KA, Shoham S, Bloch EM, Lau B, Shenoy AG, Mosnaim GS, Gniadek TJ, Fukuta Y, Patel B, Heath SL, Levine AC, Meisenberg BR, Spivak ES, Anjan S, Huaman MA, Blair JE, Currier JS, Paxton JH, Gerber JM, Petrini JR, Broderick PB, Rausch W, Cordisco ME, Hammel J, Greenblatt B, Cluzet VC, Cruser D, Oei K, Abinante M, Hammitt LL, Sutcliffe CG, Forthal DN, Zand MS, Cachay ER, Raval JS, Kassaye SG, Foster EC, Roth M, Marshall CE, Yarava A, Lane K, McBee NA, Gawad AL, Karlen N, Singh A, Ford DE, Jabs DA, Appel LJ, Shade DM, Ehrhardt S, Baksh SN, Laeyendecker O, Pekosz A, Klein SL, Casadevall A, Tobian AAR, Hanley DF. PMID: 34981068; PMCID: PMC8722611.
      View in: PubMed   Mentions: 2  
    83. Bamlanivimab reduces nasopharyngeal SARS-CoV-2 RNA levels but not symptom duration in non-hospitalized adults with COVID-19: A Phase 2 Randomized Clinical Trial. medRxiv. 2021 Dec 21. Chew KW, Moser C, Daar ES, Wohl DA, Li JZ, Coombs R, Ritz J, Giganti M, Javan AC, Li Y, Malvestutto C, Klekotka P, Price K, Nirula A, Fischer W, Bala V, Ribeiro RM, Perelson AS, Fletcher CV, Eron JJ, Currier JS, Hughes MD, Smith DM, ACTIV-2/A5401 Study Team. PMID: 34981077; PMCID: PMC8722620.
      View in: PubMed   Mentions: 2  
    84. Machine Learning Algorithms Using Routinely Collected Data Do Not Adequately Predict Viremia to Inform Targeted Services in Postpartum Women Living With HIV. J Acquir Immune Defic Syndr. 2021 12 15; 88(5):439-447. Murnane PM, Ayieko J, Vittinghoff E, Gandhi M, Katumbi C, Milala B, Nakaye C, Kanda P, Moodley D, Nyati ME, Loftis AJ, Fowler MG, Flynn P, Currier JS, Cohen CR. PMID: 34520443; PMCID: PMC8585692.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    85. Randomized controlled trial transfusing convalescent plasma as post-exposure prophylaxis against SARS-CoV-2 infection. medRxiv. 2021 Dec 14. Shoham S, Bloch EM, Casadevall A, Hanley D, Lau B, Gebo K, Cachay E, Kassaye SG, Paxton JH, Gerber J, Levine AC, Currier J, Patel B, Allen ES, Anjan S, Appel L, Baksh S, Blair PW, Bowen A, Broderick P, Caputo CA, Cluzet V, Cordisco ME, Cruser D, Ehrhardt S, Forthal D, Fukuta Y, Gawad AL, Gniadek T, Hammel J, Huaman MA, Jabs DA, Jedlicka A, Karlen N, Klein S, Laeyendecker O, Lane K, McBee N, Meisenberg B, Merlo C, Mosnaim G, Park HS, Pekosz A, Petrini J, Rausch W, Shade DM, Shapiro JR, Singleton JR, Sutcliffe C, Thomas DL, Yarava A, Zand M, Zenilman JM, Tobian AAR, Sullivan D. PMID: 34931202; PMCID: PMC8687473.
      View in: PubMed   Mentions:
    86. High Rates of Uncontrolled Blood Pressure in Malawian Adults Living with HIV and Hypertension. Glob Heart. 2021; 16(1):81. Hoffman RM, Chibwana F, Kahn D, Banda BA, Phiri L, Chimombo M, Kussen C, Sigauke H, Moses A, van Oosterhout JJ, Phiri S, Currier JW, Currier JS, Moucheraud C. PMID: 34909372; PMCID: PMC8663744.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    87. Cardiovascular Risk and Health Among People With Human Immunodeficiency Virus (HIV) Eligible for Primary Prevention: Insights From the REPRIEVE Trial. Clin Infect Dis. 2021 12 06; 73(11):2009-2022. Douglas PS, Umbleja T, Bloomfield GS, Fichtenbaum CJ, Zanni MV, Overton ET, Fitch KV, Kileel EM, Aberg JA, Currier J, Sponseller CA, Melbourne K, Avihingsanon A, Bustorff F, Estrada V, Ruxrungtham K, Saumoy M, Navar AM, Hoffmann U, Ribaudo HJ, Grinspoon S. PMID: 34134131; PMCID: PMC8664454.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    88. Poorer Muscle Quality and Quantity With ART Initiation Is Associated With Greater Inflammation and Immune Activation. J Acquir Immune Defic Syndr. 2021 12 01; 88(4):399-405. Kousari A, Moser C, Olefsky M, Brown TT, Currier JS, McComsey GA, Scherzinger A, Stein JH, Lake JE, Erlandson KM. PMID: 34326283; PMCID: PMC8556226.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    89. Assessment of Obesity and Cardiometabolic Status by Integrase Inhibitor Use in REPRIEVE: A Propensity-Weighted Analysis of a Multinational Primary Cardiovascular Prevention Cohort of People With Human Immunodeficiency Virus. Open Forum Infect Dis. 2021 Dec; 8(12):ofab537. Kileel EM, Lo J, Malvestutto C, Fitch KV, Zanni MV, Fichtenbaum CJ, Overton ET, Okeke NL, Kumar P, Joao E, Aberg JA, Martinez E, Currier JS, Douglas PS, Ribaudo HJ, Grinspoon SK. PMID: 34888395; PMCID: PMC8651160.
      View in: PubMed   Mentions: 10  
    90. Lower Severe Acute Respiratory Syndrome Coronavirus 2 Viral Shedding Following Coronavirus Disease 2019 Vaccination Among Healthcare Workers in Los Angeles, California. Open Forum Infect Dis. 2021 Nov; 8(11):ofab526. Adamson PC, Pfeffer MA, Arboleda VA, Garner OB, de St Maurice A, von Bredow B, Flint J, Kruglyak L, Currier JS. PMID: 35005055; PMCID: PMC8689969.
      View in: PubMed   Mentions: 2  
    91. Emergence of SARS-CoV-2 Resistance with Monoclonal Antibody Therapy. medRxiv. 2021 Sep 15. Choudhary MC, Chew KW, Deo R, Flynn JP, Regan J, Crain CR, Moser C, Hughes M, Ritz J, Ribeiro RM, Ke R, Dragavon JA, Javan AC, Nirula A, Klekotka P, Greninger AL, Fletcher CV, Daar ES, Wohl DA, Eron JJ, Currier JS, Parikh UM, Sieg SF, Perelson AS, Coombs RW, Smith DM, Li JZ, ACTIV-2/A5401 Study Team. PMID: 34545376; PMCID: PMC8452115.
      View in: PubMed   Mentions: 2  
    92. Advanced Glycation End Products Associated With Cardiometabolic Biomarkers in Treated Human Immunodeficiency Virus Infection. Open Forum Infect Dis. 2021 Oct; 8(10):ofab423. El Kamari V, Rodriguez K, Moser C, Currier JS, Kelesidis T, Stein JH, Brown TT, Howell SK, Beisswenger PJ, McComsey GA. PMID: 34631914; PMCID: PMC8496763.
      View in: PubMed   Mentions: 1  
    93. Design of the Healthcare Worker Exposure Response and Outcomes (HERO) research platform. Contemp Clin Trials. 2021 10; 109:106525. Friedland A, Hernandez AF, Anstrom KJ, Chen-Lim ML, Cohen LW, Currier JS, Forrest CB, Fraser R, Fraulo E, George A, Handberg E, Jackman J, Koellhoffer J, Lawrence D, Leverty R, McAdams P, McCourt B, Mickley B, Naqvi SH, O'Brien EC, Olson R, Prater C, Rothman RL, Shenkman E, Shostak J, Turner KB, Webb L, Woods C, Naggie S, HERO Research Program. PMID: 34371163; PMCID: PMC8349387.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    94. Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV): Designing Master Protocols for Evaluation of Candidate COVID-19 Therapeutics. Ann Intern Med. 2021 09; 174(9):1293-1300. LaVange L, Adam SJ, Currier JS, Higgs ES, Reineck LA, Hughes EA, Read SW, ACTIV Therapeutics-Clinical Working Group. PMID: 34181444; PMCID: PMC8244665.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCellsPHPublic Health
    95. Assessment of Coronary Artery Disease With Computed Tomography Angiography and Inflammatory and Immune Activation Biomarkers Among Adults With HIV Eligible for Primary Cardiovascular Prevention. JAMA Netw Open. 2021 06 01; 4(6):e2114923. Hoffmann U, Lu MT, Foldyna B, Zanni MV, Karady J, Taron J, Zhai BK, Burdo T, Fitch KV, Kileel EM, Williams K, Fichtenbaum CJ, Overton ET, Malvestutto C, Aberg J, Currier J, Sponseller CA, Melbourne K, Floris-Moore M, Van Dam C, Keefer MC, Koletar SL, Douglas PS, Ribaudo H, Mayrhofer T, Grinspoon SK, REPRIEVE trial. PMID: 34185068; PMCID: PMC8243232.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    96. Hepatotoxicity and Liver-Related Mortality in Women of Childbearing Potential Living With Human Immunodeficiency Virus and High CD4 Cell Counts Initiating Efavirenz-Containing Regimens. Clin Infect Dis. 2021 04 26; 72(8):1342-1349. Bhattacharya D, Gupta A, Tierney C, Huang S, Peters MG, Chipato T, Martinson F, Mohtashemi N, Dula D, George K, Chaktoura N, Klingman KL, Gnanashanmugam D, Currier JS, Fowler MG. PMID: 32161944; PMCID: PMC8075031.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    97. Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial. Lancet. 2021 04 03; 397(10281):1276-1292. Lockman S, Brummel SS, Ziemba L, Stranix-Chibanda L, McCarthy K, Coletti A, Jean-Philippe P, Johnston B, Krotje C, Fairlie L, Hoffman RM, Sax PE, Moyo S, Chakhtoura N, Stringer JS, Masheto G, Korutaro V, Cassim H, Mmbaga BT, João E, Hanley S, Purdue L, Holmes LB, Momper JD, Shapiro RL, Thoofer NK, Rooney JF, Frenkel LM, Amico KR, Chinula L, Currier J, IMPAACT 2010/VESTED Study Team and Investigators. PMID: 33812487; PMCID: PMC8132194.
      View in: PubMed   Mentions: 51     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    98. Brief Report: Impact of ART on Maternal Health After Cessation of Breastfeeding. J Acquir Immune Defic Syndr. 2021 04 01; 86(4):450-454. Brummel SS, Taha TE, Angelidou KN, Saidi F, Atuhaire P, Dula D, Moodley D, Matubu A, Chareka G, Nevrekar N, Vhembo T, Fairlie L, Theron G, Mlay P, George K, Basar M, Chakhtoura N, Browning R, Fowler MG, Currier JS, IMPAACT 1077BF/FF PROMISE Study Team. PMID: 33273210; PMCID: PMC8143379.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsPHPublic Health
    99. SARS-CoV-2 Infection after Vaccination in Health Care Workers in California. N Engl J Med. 2021 05 06; 384(18):1774-1775. Keehner J, Horton LE, Pfeffer MA, Longhurst CA, Schooley RT, Currier JS, Abeles SR, Torriani FJ. PMID: 33755376; PMCID: PMC8008750.
      View in: PubMed   Mentions: 128     Fields:    Translation:HumansCellsPHPublic Health
    100. Antiretroviral Therapy Initiation Is Associated With Decreased Visceral and Subcutaneous Adipose Tissue Density in People Living With Human Immunodeficiency Virus. Clin Infect Dis. 2021 03 15; 72(6):979-986. Debroy P, Lake JE, Moser C, Olefsky M, Erlandson KM, Scherzinger A, Stein JH, Currier JS, Brown TT, McComsey GA. PMID: 32107532; PMCID: PMC7958728.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    101. Accelerating drug discovery for pregnant and lactating women living with HIV. J Int AIDS Soc. 2021 03; 24(3):e25680. Hoffman RM, Mngqibisa R, Averitt D, Currier JS. PMID: 33665978; PMCID: PMC7933560.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansPHPublic Health
    102. HIV and women in the USA: what we know and where to go from here. Lancet. 2021 03 20; 397(10279):1107-1115. Adimora AA, Ramirez C, Poteat T, Archin NM, Averitt D, Auerbach JD, Agwu AL, Currier J, Gandhi M. PMID: 33617768.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansPHPublic Health
    103. Corrigendum to: Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE Trial. J Infect Dis. 2021 02 03; 223(2):352. Fichtenbaum CJ, Ribaudo HJ, Leon-Cruz J, Overton ET, Zanni MV, Malvestutto CD, Aberg JA, Kileel EM, Fitch KV, Van Schalkwyk M, Kumarasamy N, Martinez E, Santos BR, Joseph Y, Lo J, Siminski S, Melbourne K, Sponseller CA, Desvigne-Nickens P, Bloomfield GS, Currier JS, Hoffmann U, Douglas PS, Grinspoon SK. PMID: 33068427; PMCID: PMC8112120.
      View in: PubMed   Mentions:    Fields:    
    104. Maternal HBV Viremia and Association With Adverse Infant Outcomes in Women Living With HIV and HBV. Pediatr Infect Dis J. 2021 02 01; 40(2):e56-e61. Bhattacharya D, Guo R, Tseng CH, Emel L, Sun R, Chiu SH, Stranix-Chibanda L, Chipato T, Mohtashemi NZ, Kintu K, Manji KP, Moodley D, Thio CL, Maldonado Y, Currier JS. PMID: 33181788; PMCID: PMC7855346.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsPHPublic Health
    105. Non-communicable Diseases in Pregnant and Postpartum Women Living with HIV: Implications for Health Throughout the Life Course. Curr HIV/AIDS Rep. 2021 02; 18(1):73-86. Hoffman RM, Newhouse C, Chu B, Stringer JSA, Currier JS. PMID: 33400169.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    106. Effects of HIV Infection on Arterial Endothelial Function: Results From a Large Pooled Cohort Analysis. Arterioscler Thromb Vasc Biol. 2021 01; 41(1):512-522. Stein JH, Kime N, Korcarz CE, Ribaudo H, Currier JS, Delaney JC. PMID: 33327750; PMCID: PMC7770018.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    107. Methotrexate Decreases Tenofovir Exposure in Antiretroviral-Suppressed Individuals Living With HIV. J Acquir Immune Defic Syndr. 2020 12 15; 85(5):651-658. Gingrich D, Deitchman AN, Kantor A, Huang L, Stein JH, Currier JS, Hsue PY, Ribaudo HJ, Aweeka FT, ACTG 5314 Protocol Team. PMID: 33177476; PMCID: PMC8132144.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    108. Excess Patient Visits for Cough and Pulmonary Disease at a Large US Health System in the Months Prior to the COVID-19 Pandemic: Time-Series Analysis. J Med Internet Res. 2020 09 10; 22(9):e21562. Elmore JG, Wang PC, Kerr KF, Schriger DL, Morrison DE, Brookmeyer R, Pfeffer MA, Payne TH, Currier JS. PMID: 32791492; PMCID: PMC7485935.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCellsPHPublic Health
    109. Short Communication: Impact of Fat Changes on the Effect of Protease Inhibitors on Lumbar Spine Bone Mineral Density Changes with Antiretroviral Therapy Initiation. AIDS Res Hum Retroviruses. 2020 10; 36(10):831-834. Garza J, Moser C, Kitch DW, Currier JS, Dubé MP, Stein J, McComsey G, Brown TT. PMID: 32623904; PMCID: PMC7548021.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    110. Myocardial Steatosis Among Antiretroviral Therapy-Treated People With Human Immunodeficiency Virus Participating in the REPRIEVE Trial. J Infect Dis. 2020 07 09; 222(Suppl 1):S63-S69. Neilan TG, Nguyen KL, Zaha VG, Chew KW, Morrison L, Ntusi NAB, Toribio M, Awadalla M, Drobni ZD, Nelson MD, Burdo TH, Van Schalkwyk M, Sax PE, Skiest DJ, Tashima K, Landovitz RJ, Daar E, Wurcel AG, Robbins GK, Bolan RK, Fitch KV, Currier JS, Bloomfield GS, Desvigne-Nickens P, Douglas PS, Hoffmann U, Grinspoon SK, Ribaudo H, Dawson R, Goetz MB, Jain MK, Warner A, Szczepaniak LS, Zanni MV. PMID: 32645158; PMCID: PMC7347082.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    111. Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE Trial. J Infect Dis. 2020 07 09; 222(Suppl 1):S8-S19. Fichtenbaum CJ, Ribaudo HJ, Leon-Cruz J, Overton ET, Zanni MV, Malvestutto CD, Aberg JA, Kileel EM, Fitch KV, Van Schalkwyk M, Kumarasamy N, Martinez E, Santos BR, Joseph Y, Lo J, Siminski S, Melbourne K, Sponseller CA, Desvigne-Nickens P, Bloomfield GS, Currier JS, Hoffmann U, Douglas PS, Grinspoon SK, REPRIEVE Investigators. PMID: 32645162; PMCID: PMC7347081.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    112. Correlates and Timing of Reproductive Aging Transitions in a Global Cohort of Midlife Women With Human Immunodeficiency Virus: Insights From the REPRIEVE Trial. J Infect Dis. 2020 07 09; 222(Suppl 1):S20-S30. Zanni MV, Currier JS, Kantor A, Smeaton L, Rivard C, Taron J, Burdo TH, Badal-Faesen S, Lalloo UG, Pinto JA, Samaneka W, Valencia J, Klingman K, Allston-Smith B, Cooper-Arnold K, Desvigne-Nickens P, Lu MT, Fitch KV, Hoffman U, Grinspoon SK, Douglas PS, Looby SE. PMID: 32645159; PMCID: PMC7347076.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    113. "Cure" Versus "Clinical Remission": The Impact of a Medication Description on the Willingness of People Living with HIV to Take a Medication. AIDS Behav. 2020 Jul; 24(7):2054-2061. Fridman I, Ubel PA, Blumenthal-Barby J, England CV, Currier JS, Eyal N, Freedberg KA, Halpern SD, Kelley CF, Kuritzkes DR, Le CN, Lennox JL, Pollak KI, Zikmund-Fisher BJ, Scherr KA. PMID: 31900813; PMCID: PMC7319892.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    114. Erratum to: Changes in Bone Mineral Density After Initiation of Antiretroviral Treatment With Tenofovir Disoproxil Fumarate/Emtricitabine Plus Atazanavir/Ritonavir, Darunavir/Ritonavir, or Raltegravir. J Infect Dis. 2020 06 11; 221(12):2083-2084. Brown TT, Moser C, Currier JS, Ribaudo HJ, Rothenberg J, Kelesidis T, Yang O, Dubé MP, Murphy RL, Stein JH, McComsey GA. PMID: 32022230; PMCID: PMC7457181.
      View in: PubMed   Mentions:    Fields:    
    115. Immune Biomarkers in the Prediction of Future Myocardial Infarctions in People With Human Immunodeficiency Virus. Clin Infect Dis. 2020 04 10; 70(8):1764-1767. Trevillyan JM, Moser C, Currier JS, Sallam T. PMID: 31414117; PMCID: PMC7346757.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    116. Monthly Injectable Antiretroviral Therapy - Version 1.0 of a New Treatment Approach. N Engl J Med. 2020 03 19; 382(12):1164-1165. Currier JS. PMID: 32130808.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    117. Reducing cardiovascular risk among people living with HIV: Rationale and design of the INcreasing Statin Prescribing in HIV Behavioral Economics REsearch (INSPIRE) randomized controlled trial. Prog Cardiovasc Dis. 2020 Mar - Apr; 63(2):109-117. Takada S, Ober AJ, Currier JS, Goldstein NJ, Horwich TB, Mittman BS, Shu SB, Tseng CH, Vijayan T, Wali S, Cunningham WE, Ladapo JA. PMID: 32084445; PMCID: PMC8670826.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    118. The Role of Inflammation in HIV-Associated Atherosclerosis-One Size May Not Fit All. J Infect Dis. 2020 02 03; 221(4):495-497. Currier JS, Hsue PY. PMID: 31077267.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    119. Comparison of guidelines for HIV viral load monitoring among pregnant and breastfeeding women in sub-Saharan Africa. AIDS. 2020 02 01; 34(2):311-315. Lesosky M, Raboud JM, Glass T, Brummel SS, Ciaranello AL, Currier JS, Essajee S, Havlir DV, Koss CA, Ogwu A, Shapiro RL, Abrams EJ, Myer L. PMID: 31634186; PMCID: PMC7060505.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    120. The impact of short term Antiretroviral Therapy (ART) interruptions on longer term maternal health outcomes-A randomized clinical trial. PLoS One. 2020; 15(1):e0228003. Atuhaire P, S Brummel S, Mmbaga BT, Angelidou K, Fairlie L, Violari A, Theron G, Mukuzunga C, Mawlana S, Mubiana-Mbewe M, Naidoo M, Makanani B, Mandima P, Nematadzira T, Suryavanshi N, Mbengeranwa T, Loftis A, Basar M, McCarthy K, Currier JS, Fowler MG, 1077BF/1077FF PROMISE Team. PMID: 31999753; PMCID: PMC6992010.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    121. Cabotegravir Is Not Associated With Weight Gain in Human Immunodeficiency Virus-uninfected Individuals in HPTN 077. Clin Infect Dis. 2020 01 02; 70(2):319-322. Landovitz RJ, Zangeneh SZ, Chau G, Grinsztejn B, Eron JJ, Dawood H, Magnus M, Liu AY, Panchia R, Hosseinipour MC, Kofron R, Margolis DA, Rinehart A, Adeyeye A, Burns D, McCauley M, Cohen MS, Currier JS. PMID: 31125395; PMCID: PMC6938971.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    122. Predictors of Viremia in Postpartum Women on Antiretroviral Therapy. J Acquir Immune Defic Syndr. 2020 01 01; 83(1):72-80. Hoffman RM, Warshaw MG, Amico KR, Pilotto J, Masheto G, Achalapong J, Machado E, Chokephaibulkit K, Duarte G, João E, Graham KK, Knapp KM, Stek AM, Scott GB, Coletti A, Loftis AJ, Chakhtoura N, Currier JS, PROMISE 1077HS Team. PMID: 31651545; PMCID: PMC6898779.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    123. Time to viral rebound and safety after antiretroviral treatment interruption in postpartum women compared with men. AIDS. 2019 11 15; 33(14):2149-2156. Le CN, Britto P, Brummel SS, Hoffman RM, Li JZ, Flynn PM, Taha TE, Coletti A, Fowler MG, Bosch RJ, Gandhi RT, Klingman KL, McIntyre JA, Currier JS. PMID: 31373919; PMCID: PMC6832824.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    124. Changes in the Fungal Marker β-D-Glucan After Antiretroviral Therapy and Association With Adiposity. Open Forum Infect Dis. 2019 Nov; 6(11):ofz434. Dirajlal-Fargo S, Moser C, Rodriguez K, El-Kamari V, Funderburg NT, Bowman E, Brown TT, Hunt PW, Currier J, McComsey GA. PMID: 31737737; PMCID: PMC6847395.
      View in: PubMed   Mentions: 10  
    125. Linked dual-class HIV resistance mutations are associated with treatment failure. JCI Insight. 2019 10 03; 4(19). Boltz VF, Shao W, Bale MJ, Halvas EK, Luke B, McIntyre JA, Schooley RT, Lockman S, Currier JS, Sawe F, Hogg E, Hughes MD, Kearney MF, Coffin JM, Mellors JW. PMID: 31487271; PMCID: PMC6795402.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCellsCTClinical Trials
    126. Tenofovir concentrations in hair strongly predict virologic suppression in breastfeeding women. AIDS. 2019 08 01; 33(10):1657-1662. Murnane PM, Bacchetti P, Currier JS, Brummel S, Okochi H, Phung N, Louie A, Kuncze K, Hoffman RM, Nematadzira T, Soko DK, Owor M, Saidi F, Flynn PM, Fowler MG, Gandhi M. PMID: 31021852; PMCID: PMC6629471.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    127. Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart Association. Circulation. 2019 07 09; 140(2):e98-e124. Feinstein MJ, Hsue PY, Benjamin LA, Bloomfield GS, Currier JS, Freiberg MS, Grinspoon SK, Levin J, Longenecker CT, Post WS. PMID: 31154814; PMCID: PMC7993364.
      View in: PubMed   Mentions: 235     Fields:    Translation:Humans
    128. Safety and Impact of Low-dose Methotrexate on Endothelial Function and Inflammation in Individuals With Treated Human Immunodeficiency Virus: AIDS Clinical Trials Group Study A5314. Clin Infect Dis. 2019 05 17; 68(11):1877-1886. Hsue PY, Ribaudo HJ, Deeks SG, Bell T, Ridker PM, Fichtenbaum C, Daar ES, Havlir D, Yeh E, Tawakol A, Lederman M, Currier JS, Stein JH. PMID: 30219823; PMCID: PMC6522677.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCellsCTClinical Trials
    129. Lower Pretreatment Gut Integrity Is Independently Associated With Fat Gain on Antiretroviral Therapy. Clin Infect Dis. 2019 04 08; 68(8):1394-1401. El Kamari V, Moser C, Hileman CO, Currier JS, Brown TT, Johnston L, Hunt PW, McComsey GA. PMID: 30137242; PMCID: PMC6599164.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    130. CROI 2019: complications and coinfections in HIV infection. Top Antivir Med. 2019 Apr; 27(1):34-40. Currier JS, Havlir DV. PMID: 31137001; PMCID: PMC6550358.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    131. Antiretroviral Concentrations in Hair Strongly Predict Virologic Response in a Large Human Immunodeficiency Virus Treatment-naive Clinical Trial. Clin Infect Dis. 2019 03 05; 68(6):1044-1047. Gandhi M, Bacchetti P, Ofokotun I, Jin C, Ribaudo HJ, Haas DW, Sheth AN, Horng H, Phung N, Kuncze K, Okochi H, Landovitz RJ, Lennox J, Currier JS, AIDS Clinical Trials Group (ACTG) 5257 Study Team. PMID: 30184104; PMCID: PMC6399433.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    132. Rationale and design of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE). Am Heart J. 2019 06; 212:23-35. Grinspoon SK, Fitch KV, Overton ET, Fichtenbaum CJ, Zanni MV, Aberg JA, Malvestutto C, Lu MT, Currier JS, Sponseller CA, Waclawiw M, Alston-Smith B, Cooper-Arnold K, Klingman KL, Desvigne-Nickens P, Hoffmann U, Ribaudo HJ, Douglas PS, REPRIEVE Investigators. PMID: 30928825; PMCID: PMC6535121.
      View in: PubMed   Mentions: 54     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    133. Outcomes of a Career Development Program for Underrepresented Minority Investigators in the AIDS Clinical Trials Group. Open Forum Infect Dis. 2019 Mar; 6(3):ofz069. Velásquez GE, Huaman MA, Powell KR, Cohn SE, Swaminathan S, Outlaw M, Schulte G, McNeil Q, Currier JS, Del Rio C, Castillo-Mancilla J. PMID: 30895207; PMCID: PMC6419986.
      View in: PubMed   Mentions: 3  
    134. Adverse Pregnancy Outcomes Among Women Who Conceive on Antiretroviral Therapy. Clin Infect Dis. 2019 01 07; 68(2):273-279. Hoffman RM, Brummel SS, Britto P, Pilotto JH, Masheto G, Aurpibul L, Joao E, Purswani MU, Buschur S, Pierre MF, Coletti A, Chakhtoura N, Klingman KL, Currier JS, PROMISE (Promoting Maternal and Infant Safety Everywhere) 1077HS Team. PMID: 29868833; PMCID: PMC6321847.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    135. Brachial Artery Echogenicity and Grayscale Texture Changes in HIV-Infected Individuals Receiving Low-Dose Methotrexate. Arterioscler Thromb Vasc Biol. 2018 12; 38(12):2870-2878. Stein JH, Yeh E, Weber JM, Korcarz C, Ridker PM, Tawakol A, Hsue PY, Currier JS, Ribaudo H, Mitchell CKC. PMID: 30571173; PMCID: PMC6309804.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    136. Maternal health outcomes among HIV-infected breastfeeding women with high CD4 counts: results of a treatment strategy trial. HIV Clin Trials. 2018 12; 19(6):209-224. Hoffman RM, Angelidou KN, Brummel SS, Saidi F, Violari A, Dula D, Mave V, Fairlie L, Theron G, Kamateeka M, Chipato T, Chi BH, Stranix-Chibanda L, Nematadzira T, Moodley D, Bhattacharya D, Gupta A, Coletti A, McIntyre JA, Klingman KL, Chakhtoura N, Shapiro DE, Fowler MG, Currier JS, IMPAACT PROMISE 1077BF/FF team. PMID: 30890061; PMCID: PMC6428202.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    137. Changes in Waist Circumference in HIV-Infected Individuals Initiating a Raltegravir or Protease Inhibitor Regimen: Effects of Sex and Race. Open Forum Infect Dis. 2018 Nov; 5(11):ofy201. Bhagwat P, Ofotokun I, McComsey GA, Brown TT, Moser C, Sugar CA, Currier JS. PMID: 30465010; PMCID: PMC6239079.
      View in: PubMed   Mentions: 27  
    138. Pregnancy outcomes among HIV-infected women who conceived on antiretroviral therapy. PLoS One. 2018; 13(7):e0199555. Stringer EM, Kendall MA, Lockman S, Campbell TB, Nielsen-Saines K, Sawe F, Cu-Uvin S, Wu X, Currier JS. PMID: 30020964; PMCID: PMC6051581.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    139. Brief Report: Changes in Plasma RANKL-Osteoprotegerin in a Prospective, Randomized Clinical Trial of Initial Antiviral Therapy: A5260s. J Acquir Immune Defic Syndr. 2018 07 01; 78(3):362-366. Kelesidis T, Moser CB, Johnston E, Stein JH, Dube MP, Yang OO, McComsey GA, Currier JS, Brown TT. PMID: 29533303; PMCID: PMC5997510.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    140. What Is the Best Model for HIV Primary Care? Assessing the Influence of Provider Type on Outcomes of Chronic Comorbidities in HIV Infection. J Infect Dis. 2018 06 20; 218(2):337-339. Morales Rodriguez K, Khalili J, Trevillyan J, Currier J. PMID: 29481635; PMCID: PMC6927866.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    141. Soluble levels of receptor for advanced glycation endproducts and dysfunctional high-density lipoprotein in persons infected with human immunodeficiency virus: ACTG NWCS332. Medicine (Baltimore). 2018 Jun; 97(22):e10955. Kelesidis T, Kendall MA, Danoff A, Aberg JA, Currier JS, Schmidt AM. PMID: 29851842; PMCID: PMC6392937.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    142. Adiponectin and the steatosis marker Chi3L1 decrease following switch to raltegravir compared to continued PI/NNRTI-based antiretroviral therapy. PLoS One. 2018; 13(5):e0196395. Offor O, Utay N, Reynoso D, Somasunderam A, Currier J, Lake J. PMID: 29746485; PMCID: PMC5944924.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    143. Telmisartan Therapy Does Not Improve Lymph Node or Adipose Tissue Fibrosis More Than Continued Antiretroviral Therapy Alone. J Infect Dis. 2018 05 05; 217(11):1770-1781. Utay NS, Kitch DW, Yeh E, Fichtenbaum CJ, Lederman MM, Estes JD, Deleage C, Magyar C, Nelson SD, Klingman KL, Bastow B, Luque AE, McComsey GA, Douek DC, Currier JS, Lake JE, A5317 AIDS Clinical Trials Group Team. PMID: 29401318; PMCID: PMC5946950.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCTClinical Trials
    144. CROI 2018: Complications of HIV Infection and Antiretroviral Therapy. Top Antivir Med. 2018 May; 26(1):22-29. Currier JS, Havlir DV. PMID: 29727294; PMCID: PMC5963934.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    145. Birth Outcomes for Pregnant Women with HIV Using Tenofovir-Emtricitabine. N Engl J Med. 2018 04 26; 378(17):1593-1603. Rough K, Seage GR, Williams PL, Hernandez-Diaz S, Huo Y, Chadwick EG, Currier JS, Hoffman RM, Barr E, Shapiro DE, Patel K, PHACS and the IMPAACT P1025 Study Teams. PMID: 29694825; PMCID: PMC5984044.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansPHPublic Health
    146. Management of Long-Term Complications of HIV Disease: Focus on Cardiovascular Disease. Top Antivir Med. 2018 Apr; 25(4):133-137. Currier JS. PMID: 29689541; PMCID: PMC5935217.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    147. Development and validation of an assay to analyze atazanavir in human hair via liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom. 2018 Mar 15; 32(5):431-441. Phung N, Kuncze K, Okochi H, Louie A, Benet LZ, Ofokotun I, Haas DW, Currier JS, Chawana TD, Sheth AN, Bacchetti P, Gandhi M, Horng H. PMID: 29315954; PMCID: PMC5848502.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    148. Low Levels of Endothelial Progenitor Cells and Their Association with Systemic Inflammation and Monocyte Activation in Older HIV-Infected Men. AIDS Res Hum Retroviruses. 2018 01; 34(1):39-45. Seang S, Kelesidis T, Huynh D, Park S, Moe AA, Currier JS, Lake JE. PMID: 29226690; PMCID: PMC5771525.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    149. A Conversation Among the IAS-USA Board of Directors: Hot Topics and Emerging Data in HIV Research and Care. Top Antivir Med. 2017 Dec/Jan; 24(4):142-151. Benson CA, Currier JS, Del Rio C, Gallant JE, Gulick RM, Marrazzo JM, Richman DD, Saag MS, Schooley RT, Volberding PA. PMID: 28208122; PMCID: PMC5677050.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    150. Transgender Women Living with HIV Frequently Take Antiretroviral Therapy and/or Feminizing Hormone Therapy Differently Than Prescribed Due to Drug-Drug Interaction Concerns. LGBT Health. 2017 10; 4(5):371-375. Braun HM, Candelario J, Hanlon CL, Segura ER, Clark JL, Currier JS, Lake JE. PMID: 28876170; PMCID: PMC5661861.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    151. Antiretroviral initiation is associated with increased skeletal muscle area and fat content. AIDS. 2017 08 24; 31(13):1831-1838. Erlandson KM, Fiorillo S, Masawi F, Scherzinger A, McComsey GA, Lake JE, Stein JH, Currier JS, Brown TT. PMID: 28590329; PMCID: PMC5533189.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    152. Risk of Acute Myocardial Infarction Among Hepatitis C Virus (HCV)-Positive and HCV-Negative Men at Various Lipid Levels: Results From ERCHIVES. Clin Infect Dis. 2017 Aug 15; 65(4):557-565. Butt AA, Yan P, Chew KW, Currier J, Corey K, Chung RT, Shuaib A, Abou-Samra AB, Butler J, Freiberg MS. PMID: 28444148; PMCID: PMC5850566.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    153. Predictors of Impaired HDL Function in HIV-1 Infected Compared to Uninfected Individuals. J Acquir Immune Defic Syndr. 2017 07 01; 75(3):354-363. Kelesidis T, Oda MN, Borja MS, Yee Y, Ng KF, Huynh D, Elashoff D, Currier JS. PMID: 28346318; PMCID: PMC5472482.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    154. Refining Current Scientific Priorities and Identifying New Scientific Gaps in HIV-Related Heart, Lung, Blood, and Sleep Research. AIDS Res Hum Retroviruses. 2017 Sep; 33(9):889-897. Twigg HL, Crystal R, Currier J, Ridker P, Berliner N, Kiem HP, Rutherford G, Zou S, Glynn S, Wong R, Peprah E, Engelgau M, Creazzo T, Colombini-Hatch S, Caler E. PMID: 28530113; PMCID: PMC5583565.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    155. Subclinical myocardial disease by cardiac magnetic resonance imaging and spectroscopy in healthy HIV/Hepatitis C virus-coinfected persons. J Int Med Res. 2017 Dec; 45(6):1693-1707. Chew KW, Liu CY, Ambale-Venkatesh B, Liao D, Horwich TB, Lima JAC, Bluemke DA, Paul Finn J, Butt AA, Currier JS. PMID: 28606026; PMCID: PMC5805202.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    156. Practical Review of Recognition and Management of Obesity and Lipohypertrophy in Human Immunodeficiency Virus Infection. Clin Infect Dis. 2017 May 15; 64(10):1422-1429. Lake JE, Stanley TL, Apovian CM, Bhasin S, Brown TT, Capeau J, Currier JS, Dube MP, Falutz J, Grinspoon SK, Guaraldi G, Martinez E, McComsey GA, Sattler FR, Erlandson KM. PMID: 28329372; PMCID: PMC5411395.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    157. Randomized trial of stopping or continuing ART among postpartum women with pre-ART CD4 ≥ 400 cells/mm3. PLoS One. 2017; 12(5):e0176009. Currier JS, Britto P, Hoffman RM, Brummel S, Masheto G, Joao E, Santos B, Aurpibul L, Losso M, Pierre MF, Weinberg A, Gnanashanmugam D, Chakhtoura N, Klingman K, Browning R, Coletti A, Mofenson L, Shapiro D, Pilotto J, 1077HS PROMISE Team. PMID: 28489856; PMCID: PMC5425014.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    158. CROI 2017: Complications and Comorbidities of HIV Disease and Its Treatment. Top Antivir Med. 2017 May/Jun; 25(2):77-83. Currier JS, Havlir DV. PMID: 28598792; PMCID: PMC5677045.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    159. Factors associated with retention in Option B+ in Malawi: a case control study. J Int AIDS Soc. 2017 Apr 27; 20(1):21464. Hoffman RM, Phiri K, Parent J, Grotts J, Elashoff D, Kawale P, Yeatman S, Currier JS, Schooley A. PMID: 28453243; PMCID: PMC5515033.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansPHPublic Health
    160. Changes in abdominal fat following antiretroviral therapy initiation in HIV-infected individuals correlate with waist circumference and self-reported changes. Antivir Ther. 2017; 22(7):577-586. Bhagwat P, Ofotokun I, McComsey GA, Brown TT, Moser C, Sugar CA, Currier JS. PMID: 28248190; PMCID: PMC5610106.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    161. Follow YOUR Heart: development of an evidence-based campaign empowering older women with HIV to participate in a large-scale cardiovascular disease prevention trial. HIV Clin Trials. 2017 03; 18(2):83-91. Zanni MV, Fitch K, Rivard C, Sanchez L, Douglas PS, Grinspoon S, Smeaton L, Currier JS, Looby SE. PMID: 28277924; PMCID: PMC5607953.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    162. HIV Transmission Risk Behavior in a Cohort of HIV-Infected Treatment-Naïve Men and Women in the United States. AIDS Behav. 2016 12; 20(12):2983-2995. Landovitz RJ, Tran TT, Cohn SE, Ofotokun I, Godfrey C, Kuritzkes DR, Lennox JL, Currier JS, Ribaudo HJ. PMID: 26979419; PMCID: PMC5026544.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    163. Oxidized lipoproteins are associated with markers of inflammation and immune activation in HIV-1 infection. AIDS. 2016 11 13; 30(17):2625-2633. Kelesidis T, Jackson N, McComsey GA, Wang X, Elashoff D, Dube MP, Brown TT, Yang OO, Stein JH, Currier JS. PMID: 27603288; PMCID: PMC5083154.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    164. Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention. N Engl J Med. 2016 11 03; 375(18):1726-1737. Fowler MG, Qin M, Fiscus SA, Currier JS, Flynn PM, Chipato T, McIntyre J, Gnanashanmugam D, Siberry GK, Coletti AS, Taha TE, Klingman KL, Martinson FE, Owor M, Violari A, Moodley D, Theron GB, Bhosale R, Bobat R, Chi BH, Strehlau R, Mlay P, Loftis AJ, Browning R, Fenton T, Purdue L, Basar M, Shapiro DE, Mofenson LM, IMPAACT 1077BF/1077FF PROMISE Study Team. PMID: 27806243; PMCID: PMC5214343.
      View in: PubMed   Mentions: 153     Fields:    Translation:HumansPHPublic Health
    165. Sex-Related Differences in Inflammatory and Immune Activation Markers Before and After Combined Antiretroviral Therapy Initiation. J Acquir Immune Defic Syndr. 2016 10 01; 73(2):123-9. Mathad JS, Gupte N, Balagopal A, Asmuth D, Hakim J, Santos B, Riviere C, Hosseinipour M, Sugandhavesa P, Infante R, Pillay S, Cardoso SW, Mwelase N, Pawar J, Berendes S, Kumarasamy N, Andrade BB, Campbell TB, Currier JS, Cohn SE, Gupta A, New Work Concept Sheet 319 and AIDS Clinical Trials Group A5175 (PEARLS) Study Teams. PMID: 27258230; PMCID: PMC5023467.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    166. Changes in plasma levels of oxidized lipoproteins and lipoprotein subfractions with atazanavir-, raltegravir-, darunavir-based initial antiviral therapy and associations with common carotid artery intima-media thickness: ACTG 5260s. Antivir Ther. 2017; 22(2):113-126. Kelesidis T, Tran TTT, Brown TT, Moser C, Ribaudo HJ, Dube MP, Yang OO, McComsey GA, Stein JH, Currier JS. PMID: 27661466; PMCID: PMC5364070.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    167. Telmisartan increases vascular reparative capacity in older HIV-infected adults: a pilot study. HIV Clin Trials. 2016 11; 17(6):225-232. Lake JE, Seang S, Kelesidis T, Currier JS, Yang OO. PMID: 27658740; PMCID: PMC5470589.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    168. Changes in Insulin Resistance After Initiation of Raltegravir or Protease Inhibitors With Tenofovir-Emtricitabine: AIDS Clinical Trials Group A5260s. Open Forum Infect Dis. 2016 Sep; 3(3):ofw174. Dirajlal-Fargo S, Moser C, Brown TT, Kelesidis T, Dube MP, Stein JH, Currier J, McComsey GA. PMID: 27704026; PMCID: PMC5047417.
      View in: PubMed   Mentions: 20  
    169. Traditional and HIV-specific risk factors for cardiovascular morbidity and mortality among HIV-infected adults in Brazil: a retrospective cohort study. BMC Infect Dis. 2016 Aug 08; 16:376. Diaz CM, Segura ER, Luz PM, Clark JL, Ribeiro SR, De Boni R, Eksterman L, Moreira R, Currier JS, Veloso VG, Grinsztejn B, Lake JE. PMID: 27503230; PMCID: PMC4977901.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    170. Soluble Levels of Receptor for Advanced Glycation Endproducts (RAGE) and Progression of Atherosclerosis in Individuals Infected with Human Immunodeficiency Virus: ACTG NWCS 332. Inflammation. 2016 Aug; 39(4):1354-62. Danoff A, Kendall MA, Currier JS, Kelesidis T, Schmidt AM, Aberg JA. PMID: 27216802; PMCID: PMC5053332.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    171. Reimann's "Habitual Hyperthermia" Responding to Hormone Therapy. Open Forum Infect Dis. 2016 Sep; 3(3):ofw127. Yang OO, Currier JS. PMID: 27800522; PMCID: PMC5084720.
      View in: PubMed   Mentions: 2  
    172. Changes in Markers of T-Cell Senescence and Exhaustion With Atazanavir-, Raltegravir-, and Darunavir-Based Initial Antiviral Therapy: ACTG 5260s. J Infect Dis. 2016 09 01; 214(5):748-52. Kelesidis T, Moser C, Stein JH, Brown TT, Tran TT, Ribaudo HJ, Dube MP, Yang OO, Currier JS, McComsey GA. PMID: 27354367; PMCID: PMC4978379.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    173. Making waves: safety and efficacy of ART in women. Lancet HIV. 2016 09; 3(9):e398-e399. Currier JS, Lockman S. PMID: 27562733.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    174. CROI 2016: Complications of HIV Infection and Antiretroviral Therapy. Top Antivir Med. 2016 May-Jun; 24(1):38-46. Havlir DV, Currier JS. PMID: 27398861; PMCID: PMC6148923.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    175. HIV Infection and Carotid Artery Intima-media Thickness: Pooled Analyses Across 5 Cohorts of the NHLBI HIV-CVD Collaborative. Clin Infect Dis. 2016 07 15; 63(2):249-56. Hanna DB, Guo M, Bužková P, Miller TL, Post WS, Stein JH, Currier JS, Kronmal RA, Freiberg MS, Bennett SN, Shikuma CM, Anastos K, Li Y, Tracy RP, Hodis HN, Delaney JA, Kaplan RC. PMID: 27118787; PMCID: PMC4928384.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    176. Supporting Treatment Adherence Readiness through Training (START) for patients with HIV on antiretroviral therapy: study protocol for a randomized controlled trial. Trials. 2016 Mar 24; 17:162. Wagner GJ, Linnemayr S, Ghosh-Dastidar B, Currier JS, Hoffman R, Schneider S. PMID: 27009061; PMCID: PMC4806419.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    177. Body Composition Changes After Initiation of Raltegravir or Protease Inhibitors: ACTG A5260s. Clin Infect Dis. 2016 Apr 01; 62(7):853-62. McComsey GA, Moser C, Currier J, Ribaudo HJ, Paczuski P, Dubé MP, Kelesidis T, Rothenberg J, Stein JH, Brown TT. PMID: 26797215; PMCID: PMC4787610.
      View in: PubMed   Mentions: 79     Fields:    Translation:Humans
    178. A Cure for HIV Infection: "Not in My Lifetime" or "Just Around the Corner"? Pathog Immun. 2016; 1(1):154-164. Lederman MM, Cannon PM, Currier JS, June CH, Kiem HP, Kuritzkes DR, Lewin SR, Margolis DM, McCune JM, Mellors JW, Schacker TW, Sekaly RP, Tebas P, Walker BD, Douek DC. PMID: 27668293; PMCID: PMC5033048.
      View in: PubMed   Mentions: 24  
    179. Vitamin D Levels and Markers of Inflammation and Metabolism in HIV-Infected Individuals on Suppressive Antiretroviral Therapy. AIDS Res Hum Retroviruses. 2016 Mar; 32(3):247-54. Hoffman RM, Lake JE, Wilhalme HM, Tseng CH, Currier JS. PMID: 26569649; PMCID: PMC4779972.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    180. Virologic and immunologic effects of adding maraviroc to suppressive antiretroviral therapy in individuals with suboptimal CD4+ T-cell recovery. AIDS. 2015 Oct 23; 29(16):2121-9. Cillo AR, Hilldorfer BB, Lalama CM, McKinnon JE, Coombs RW, Tenorio AR, Fox L, Gandhi RT, Ribaudo H, Currier JS, Gulick RM, Wilkin TJ, Mellors JW. PMID: 26544577; PMCID: PMC4638139.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCellsCTClinical Trials
    181. Telmisartan to reduce cardiovascular risk in older HIV-infected adults: a pilot study. HIV Clin Trials. 2015 Oct; 16(5):197-206. Lake JE, Seang S, Kelesidis T, Liao DH, Hodis HN, Stein JH, Currier JS. PMID: 26360501; PMCID: PMC4701215.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    182. A prospective, randomized clinical trial of antiretroviral therapies on carotid wall thickness. AIDS. 2015 Sep 10; 29(14):1775-83. Stein JH, Ribaudo HJ, Hodis HN, Brown TT, Tran TT, Yan M, Brodell EL, Kelesidis T, McComsey GA, Dube MP, Murphy RL, Currier JS. PMID: 26372383; PMCID: PMC4571277.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCellsCTClinical Trials
    183. Vitamin D3 supplementation in HIV infection: effectiveness and associations with antiretroviral therapy. Nutr J. 2015 Aug 18; 14:81. Coelho L, Cardoso SW, Luz PM, Hoffman RM, Mendonça L, Veloso VG, Currier JS, Grinsztejn B, Lake JE. PMID: 26283663; PMCID: PMC4538921.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCTClinical Trials
    184. Screening for UGT1A1 Genotype in Study A5257 Would Have Markedly Reduced Premature Discontinuation of Atazanavir for Hyperbilirubinemia. Open Forum Infect Dis. 2015 Sep; 2(3):ofv085. Vardhanabhuti S, Ribaudo HJ, Landovitz RJ, Ofotokun I, Lennox JL, Currier JS, Olson LM, Haas DW. PMID: 26180834; PMCID: PMC4498287.
      View in: PubMed   Mentions: 10  
    185. Comparison of HBV-active HAART regimens in an HIV-HBV multinational cohort: outcomes through 144 weeks. AIDS. 2015 Jun 19; 29(10):1173-82. Thio CL, Smeaton L, Hollabaugh K, Saulynas M, Hwang H, Saravanan S, Kulkarni S, Hakim J, Nyirenda M, Iqbal HS, Lalloo UG, Campbell TB, Lockman S, Currier JS. PMID: 26035319; PMCID: PMC4535336.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    186. Benefits of PrEP as an Adjunctive Method of HIV Prevention During Attempted Conception Between HIV-uninfected Women and HIV-infected Male Partners. J Infect Dis. 2015 Nov 15; 212(10):1534-43. Hoffman RM, Jaycocks A, Vardavas R, Wagner G, Lake JE, Mindry D, Currier JS, Landovitz RJ. PMID: 26092856; PMCID: PMC4621256.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansPHPublic Health
    187. Success of Standard Dose Vitamin D Supplementation in Treated Human Immunodeficiency Virus Infection. Open Forum Infect Dis. 2015 Apr; 2(2):ofv068. Lake JE, Hoffman RM, Tseng CH, Wilhalme HM, Adams JS, Currier JS. PMID: 26125033; PMCID: PMC4462892.
      View in: PubMed   Mentions: 6  
    188. Extended-Release Niacin Versus Fenofibrate in HIV-Infected Participants With Low High-Density Lipoprotein Cholesterol: Effects on Endothelial Function, Lipoproteins, and Inflammation. Clin Infect Dis. 2015 Sep 01; 61(5):840-9. Dubé MP, Komarow L, Fichtenbaum CJ, Cadden JJ, Overton ET, Hodis HN, Currier JS, Stein JH, AIDS Clinical Trials Group A5293 Study Team. PMID: 25979307; PMCID: PMC4580531.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    189. Short Communication: Coronary Heart Disease Risk by Framingham Risk Score in Hepatitis C and HIV/Hepatitis C-Coinfected Persons. AIDS Res Hum Retroviruses. 2015 Jul; 31(7):718-22. Chew KW, Bhattacharya D, McGinnis KA, Horwich TB, Tseng CH, Currier JS, Butt AA, ERCHIVES (Electronically Retrieved Cohort of HCV Infected Veterans) Study. PMID: 25858663; PMCID: PMC4505770.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    190. Changes in Bone Mineral Density After Initiation of Antiretroviral Treatment With Tenofovir Disoproxil Fumarate/Emtricitabine Plus Atazanavir/Ritonavir, Darunavir/Ritonavir, or Raltegravir. J Infect Dis. 2015 Oct 15; 212(8):1241-9. Brown TT, Moser C, Currier JS, Ribaudo HJ, Rothenberg J, Kelesidis T, Yang O, Dubé MP, Murphy RL, Stein JH, McComsey GA. PMID: 25948863; PMCID: PMC4577040.
      View in: PubMed   Mentions: 56     Fields:    Translation:HumansCells
    191. Switch to Raltegravir From Protease Inhibitor or Nonnucleoside Reverse-Transcriptase Inhibitor Does not Reduce Visceral Fat In Human Immunodeficiency Virus-Infected Women With Central Adiposity. Open Forum Infect Dis. 2015 Apr; 2(2):ofv059. Lake JE, McComsey GA, Hulgan T, Wanke CA, Mangili A, Walmsley SL, Currier JS. PMID: 26380350; PMCID: PMC4567084.
      View in: PubMed   Mentions: 3  
    192. Changes in Inflammation and Immune Activation With Atazanavir-, Raltegravir-, Darunavir-Based Initial Antiviral Therapy: ACTG 5260s. Clin Infect Dis. 2015 Aug 15; 61(4):651-60. Kelesidis T, Tran TT, Stein JH, Brown TT, Moser C, Ribaudo HJ, Dube MP, Murphy R, Yang OO, Currier JS, McComsey GA. PMID: 25904376; PMCID: PMC4542595.
      View in: PubMed   Mentions: 71     Fields:    Translation:Humans
    193. Concurrent Anemia and Elevated C-Reactive Protein Predicts HIV Clinical Treatment Failure, Including Tuberculosis, After Antiretroviral Therapy Initiation. Clin Infect Dis. 2015 Jul 01; 61(1):102-10. Shivakoti R, Yang WT, Gupte N, Berendes S, Rosa AL, Cardoso SW, Mwelase N, Kanyama C, Pillay S, Samaneka W, Riviere C, Sugandhavesa P, Santos B, Poongulali S, Tripathy S, Bollinger RC, Currier JS, Tang AM, Semba RD, Christian P, Campbell TB, Gupta A, New Work Concept Sheet 319 and The Prospective Evaluation of Antiretrovirals in Resource-Limited Set. PMID: 25828994; PMCID: PMC4542913.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    194. Comparison of the metabolic effects of ritonavir-boosted darunavir or atazanavir versus raltegravir, and the impact of ritonavir plasma exposure: ACTG 5257. Clin Infect Dis. 2015 06 15; 60(12):1842-51. Ofotokun I, Na LH, Landovitz RJ, Ribaudo HJ, McComsey GA, Godfrey C, Aweeka F, Cohn SE, Sagar M, Kuritzkes DR, Brown TT, Patterson KB, Para MF, Leavitt RY, Villasis-Keever A, Baugh BP, Lennox JL, Currier JS, AIDS Clinical Trials Group (ACTG) A5257 Team. PMID: 25767256; PMCID: PMC4660025.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCellsCTClinical Trials
    195. CROI 2015: Complications of HIV Infection and Antiretroviral Therapy. Top Antivir Med. 2015 Mar-Apr; 23(1):56-65. Havlir DV, Currier JS. PMID: 25965312; PMCID: PMC6148904.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    196. Stimulating high impact HIV-related cardiovascular research: recommendations from a multidisciplinary NHLBI Working Group on HIV-related heart, lung, and blood disease. J Am Coll Cardiol. 2015 Feb 24; 65(7):738-44. Shah MR, Cook N, Wong R, Hsue P, Ridker P, Currier J, Shurin S. PMID: 25677433; PMCID: PMC4330466.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    197. The effect of hepatitis C virologic clearance on cardiovascular disease biomarkers in human immunodeficiency virus/hepatitis C virus coinfection. Open Forum Infect Dis. 2014 Dec; 1(3):ofu104. Chew KW, Hua L, Bhattacharya D, Butt AA, Bornfleth L, Chung RT, Andersen JW, Currier JS. PMID: 25734172; PMCID: PMC4324212.
      View in: PubMed   Mentions: 17  
    198. A high throughput biochemical fluorometric method for measuring lipid peroxidation in HDL. PLoS One. 2014; 9(11):e111716. Kelesidis T, Roberts CK, Huynh D, Martínez-Maza O, Currier JS, Reddy ST, Yang OO. PMID: 25368900; PMCID: PMC4219769.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansAnimalsCells
    199. Who Provides Primary Care? An Assessment of HIV Patient and Provider Practices and Preferences. J AIDS Clin Res. 2014 Nov; 5(11). Cheng QJ, Engelage EM, Grogan TR, Currier JS, Hoffman RM. PMID: 25914854; PMCID: PMC4409003.
      View in: PubMed   Mentions: 23  
    200. Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1: a randomized, controlled equivalence trial. Ann Intern Med. 2014 Oct 07; 161(7):461-71. Lennox JL, Landovitz RJ, Ribaudo HJ, Ofotokun I, Na LH, Godfrey C, Kuritzkes DR, Sagar M, Brown TT, Cohn SE, McComsey GA, Aweeka F, Fichtenbaum CJ, Presti RM, Koletar SL, Haas DW, Patterson KB, Benson CA, Baugh BP, Leavitt RY, Rooney JF, Seekins D, Currier JS, ACTG A5257 Team. PMID: 25285539; PMCID: PMC4412467.
      View in: PubMed   Mentions: 101     Fields:    Translation:HumansCellsCTClinical Trials
    201. Proteinuria is associated with neurocognitive impairment in antiretroviral therapy treated HIV-infected individuals. J Acquir Immune Defic Syndr. 2014 Sep 01; 67(1):30-5. Kalayjian RC, Wu K, Evans S, Clifford DB, Pallaki M, Currier JS, Smryzynski M. PMID: 25118793; PMCID: PMC4133749.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    202. Dyslipidemia and cardiovascular risk in human immunodeficiency virus infection. Endocrinol Metab Clin North Am. 2014 Sep; 43(3):665-84. Kelesidis T, Currier JS. PMID: 25169560; PMCID: PMC5054418.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    203. Role of RANKL-RANK/osteoprotegerin pathway in cardiovascular and bone disease associated with HIV infection. AIDS Rev. 2014 Jul-Sep; 16(3):123-33. Kelesidis T, Currier JS, Yang OO, Brown TT. PMID: 25102334; PMCID: PMC5067015.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    204. Predictors of suboptimal CD4 response among women achieving virologic suppression in a randomized antiretroviral treatment trial, Africa. BMC Infect Dis. 2014 Jun 17; 14:331. Asmelash A, Zheng Y, Kaloustian KW, Shaffer D, Sawe F, Ogwu A, Salata R, Currier J, Hughes MD, Lockman S. PMID: 24938526; PMCID: PMC4083139.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    205. Urinary eicosanoid metabolites in HIV-infected women with central obesity switching to raltegravir: an analysis from the women, integrase, and fat accumulation trial. Mediators Inflamm. 2014; 2014:803095. Hulgan T, Boger MS, Liao DH, McComsey GA, Wanke CA, Mangili A, Walmsley SL, McCreath H, Milne GL, Sanchez SC, Currier JS, Lake JE. PMID: 24991090; PMCID: PMC4058804.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    206. Cardiovascular disease risk factors in HIV-infected women after initiation of lopinavir/ritonavir- and nevirapine-based antiretroviral therapy in Sub-Saharan Africa: A5208 (OCTANE). J Acquir Immune Defic Syndr. 2014 Jun 01; 66(2):155-63. Shaffer D, Hughes MD, Sawe F, Bao Y, Moses A, Hogg E, Lockman S, Currier J. PMID: 24562349; PMCID: PMC4109714.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    207. Antiretroviral therapy and efficacy after virologic failure on first-line boosted protease inhibitor regimens. Clin Infect Dis. 2014 Sep 15; 59(6):888-96. Zheng Y, Hughes MD, Lockman S, Benson CA, Hosseinipour MC, Campbell TB, Gulick RM, Daar ES, Sax PE, Riddler SA, Haubrich R, Salata RA, Currier JS. PMID: 24842909; PMCID: PMC4155445.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    208. Renal events among women treated with tenofovir/emtricitabine in combination with either lopinavir/ritonavir or nevirapine. AIDS. 2014 May 15; 28(8):1135-42. Mwafongo A, Nkanaunena K, Zheng Y, Hogg E, Samaneka W, Mulenga L, Siika A, Currier J, Lockman S, Hughes MD, Hosseinipour M, AIDS Clinical Trial Group (ACTG) A5208 Team. PMID: 24445367; PMCID: PMC4176616.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCellsCTClinical Trials
    209. CROI 2014: Viral hepatitis and complications of HIV disease and antiretroviral therapy. Top Antivir Med. 2014 May; 22(2):602-15. Luetkemeyer AF, Havlir DV, Currier JS. PMID: 24901886; PMCID: PMC6148912.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    210. Arterial disease in patients with human immunodeficiency virus infection: what has imaging taught us? JACC Cardiovasc Imaging. 2014 May; 7(5):515-25. Stein JH, Currier JS, Hsue PY. PMID: 24831212; PMCID: PMC4024182.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCells
    211. HIV and atherosclerosis: moving from associations to mechanisms and interventions. Ann Intern Med. 2014 Apr 01; 160(7):509-10. Currier JS, Stein JH. PMID: 24687073.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    212. Immune activation markers in peripartum women in Botswana: association with feeding strategy and maternal morbidity. PLoS One. 2014; 9(3):e89928. Russell ES, Mohammed T, Smeaton L, Jorowe B, MacLeod IJ, Hoffman RM, Currier JS, Moyo S, Essex M, Lockman S. PMID: 24657960; PMCID: PMC3962339.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    213. HDL redox activity is increased in HIV-infected men in association with macrophage activation and non-calcified coronary atherosclerotic plaque. Antivir Ther. 2014; 19(8):805-811. Zanni MV, Kelesidis T, Fitzgerald ML, Lo J, Abbara S, Wai B, Marmarelis E, Hernandez NJ, Yang OO, Currier JS, Grinspoon SK. PMID: 24535655; PMCID: PMC4423391.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    214. Metabolic disease in HIV infection. Lancet Infect Dis. 2013 Nov; 13(11):964-75. Lake JE, Currier JS. PMID: 24156897.
      View in: PubMed   Mentions: 88     Fields:    Translation:HumansCells
    215. Biomarkers from late pregnancy to 6 weeks postpartum in HIV-infected women who continue versus discontinue antiretroviral therapy after delivery. J Acquir Immune Defic Syndr. 2013 Aug 15; 63(5):593-601. Hoffman RM, Leister E, Kacanek D, Shapiro DE, Read JS, Bryson Y, Currier JS. PMID: 23714738; PMCID: PMC3868443.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    216. Body composition, soluble markers of inflammation, and bone mineral density in antiretroviral therapy-naive HIV-1-infected individuals. J Acquir Immune Defic Syndr. 2013 Jul 01; 63(3):323-30. Brown TT, Chen Y, Currier JS, Ribaudo HJ, Rothenberg J, Dubé MP, Murphy R, Stein JH, McComsey GA. PMID: 23591634; PMCID: PMC3693854.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCellsCTClinical Trials
    217. Insights on GRACE (Gender, Race, And Clinical Experience) from the patient's perspective: GRACE participant survey. AIDS Patient Care STDS. 2013 Jun; 27(6):352-62. Squires K, Feinberg J, Bridge DA, Currier J, Ryan R, Seyedkazemi S, Dayaram YK, Mrus J. PMID: 23701200; PMCID: PMC3696933.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    218. CROI 2013: Complications of HIV disease, viral hepatitis, and antiretroviral therapy. Top Antivir Med. 2013 Apr-May; 21(2):62-74. Luetkemeyer AF, Havlir DV, Currier JS. PMID: 23681961; PMCID: PMC6148869.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    219. Ultrasonographic measures of cardiovascular disease risk in antiretroviral treatment-naive individuals with HIV infection. AIDS. 2013 Mar 27; 27(6):929-937. Stein JH, Brown TT, Ribaudo HJ, Chen Y, Yan M, Lauer-Brodell E, McComsey GA, Dubé MP, Murphy RL, Hodis HN, Currier JS. PMID: 23196938; PMCID: PMC3664137.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    220. A pilot study of telmisartan for visceral adiposity in HIV infection: the metabolic abnormalities, telmisartan, and HIV infection (MATH) trial. PLoS One. 2013; 8(3):e58135. Lake JE, Tseng CH, Currier JS. PMID: 23516440; PMCID: PMC3597631.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    221. Dysfunctional HDL and progression of atherosclerosis in HIV-1-infected and -uninfected adults. Lipids Health Dis. 2013 Mar 05; 12:23. Kelesidis T, Yang OO, Kendall MA, Hodis HN, Currier JS. PMID: 23510548; PMCID: PMC3602051.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    222. Perturbations of circulating levels of RANKL-osteoprotegerin axis in relation to lipids and progression of atherosclerosis in HIV-infected and -uninfected adults: ACTG NWCS 332/A5078 Study. AIDS Res Hum Retroviruses. 2013 Jun; 29(6):938-48. Kelesidis T, Kendall MA, Yang OO, Hodis H, Currier JS. PMID: 23351153; PMCID: PMC3653400.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    223. Moderate prevalence of transmitted drug resistance mutations among antiretroviral-naive HIV-infected pregnant women in Rio de Janeiro, Brazil. AIDS Res Hum Retroviruses. 2013 Apr; 29(4):681-6. Pilotto JH, Grinsztejn B, Veloso VG, Velasque LS, Friedman RK, Moreira RI, Rodrigues-Pedro A, Oliveira SM, Currier JS, Morgado MG. PMID: 23259924.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    224. Characterization of HIV-HBV coinfection in a multinational HIV-infected cohort. AIDS. 2013 Jan 14; 27(2):191-201. Thio CL, Smeaton L, Saulynas M, Hwang H, Saravanan S, Saravan S, Kulkarni S, Hakim J, Nyirenda M, Iqbal HS, Lalloo UG, Mehta AS, Hollabaugh K, Campbell TB, Lockman S, Currier JS. PMID: 23032418; PMCID: PMC3763734.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    225. Biomarkers of microbial translocation and macrophage activation: association with progression of subclinical atherosclerosis in HIV-1 infection. J Infect Dis. 2012 Nov 15; 206(10):1558-67. Kelesidis T, Kendall MA, Yang OO, Hodis HN, Currier JS. PMID: 23066162; PMCID: PMC3475633.
      View in: PubMed   Mentions: 128     Fields:    Translation:HumansCells
    226. A randomized trial of Raltegravir replacement for protease inhibitor or non-nucleoside reverse transcriptase inhibitor in HIV-infected women with lipohypertrophy. AIDS Patient Care STDS. 2012 Sep; 26(9):532-40. Lake JE, McComsey GA, Hulgan TM, Wanke CA, Mangili A, Walmsley SL, Boger MS, Turner RR, McCreath HE, Currier JS. PMID: 22823027; PMCID: PMC3426192.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    227. HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group. J Acquir Immune Defic Syndr. 2012 Jul 01; 60 Suppl 1:S1-18. High KP, Brennan-Ing M, Clifford DB, Cohen MH, Currier J, Deeks SG, Deren S, Effros RB, Gebo K, Goronzy JJ, Justice AC, Landay A, Levin J, Miotti PG, Munk RJ, Nass H, Rinaldo CR, Shlipak MG, Tracy R, Valcour V, Vance DE, Walston JD, Volberding P, OAR Working Group on HIV and Aging. PMID: 22688010; PMCID: PMC3413877.
      View in: PubMed   Mentions: 294     Fields:    Translation:Humans
    228. Assessing darunavir/ritonavir-based therapy in a racially diverse population: 48-week outcomes from GRACE. J Natl Med Assoc. 2012 Jul-Aug; 104(7-8):366-76. Smith KY, Garcia F, Kumar P, Currier JS, Ryan R, Falcon R, Mrus J, Squires K. PMID: 23092052.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCellsCTClinical Trials
    229. A pilot trial of adding maraviroc to suppressive antiretroviral therapy for suboptimal CD4⁺ T-cell recovery despite sustained virologic suppression: ACTG A5256. J Infect Dis. 2012 Aug 15; 206(4):534-42. Wilkin TJ, Lalama CM, McKinnon J, Gandhi RT, Lin N, Landay A, Ribaudo H, Fox L, Currier JS, Mellors JW, Gulick R, Tenorio AR. PMID: 22740718; PMCID: PMC3491731.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansCellsCTClinical Trials
    230. Nevirapine- versus lopinavir/ritonavir-based initial therapy for HIV-1 infection among women in Africa: a randomized trial. PLoS Med. 2012; 9(6):e1001236. Lockman S, Hughes M, Sawe F, Zheng Y, McIntyre J, Chipato T, Asmelash A, Rassool M, Kimaiyo S, Shaffer D, Hosseinipour M, Mohapi L, Ssali F, Chibowa M, Amod F, Halvas E, Hogg E, Alston-Smith B, Smith L, Schooley R, Mellors J, Currier J, OCTANE (Optimal Combination Therapy After Nevirapine Exposure) ACTG A5208/OCTANE Study Team. PMID: 22719231; PMCID: PMC3373629.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    231. Complications of HIV disease and antiretroviral therapy. Top Antivir Med. 2012 Jun-Jul; 20(2):48-60. Luetkemeyer AF, Havlir DV, Currier JS. PMID: 22710907; PMCID: PMC6148866.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    232. Infant outcomes after maternal antiretroviral exposure in resource-limited settings. Pediatrics. 2012 Jun; 129(6):e1525-32. Nielsen-Saines K, Komarow L, Cu-Uvin S, Jourdain G, Klingman KL, Shapiro DE, Mofenson L, Moran L, Campbell TB, Hitti J, Fiscus S, Currier J, ACTG 5190/PACTG 1054 Study Team. PMID: 22585772; PMCID: PMC3362906.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    233. Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Los Angeles County. J Med Virol. 2012 May; 84(5):777-85. Kelesidis T, Humphries R, Terashita D, Eshaghian S, Territo MC, Said J, Lewinski M, Currier JS, Pegues D. PMID: 22431026; PMCID: PMC8067666.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    234. Nevirapine pharmacokinetics and risk of rash and hepatitis among HIV-infected sub-Saharan African women. AIDS. 2012 Apr 24; 26(7):833-41. Dong BJ, Zheng Y, Hughes MD, Frymoyer A, Verotta D, Lizak P, Sawe F, Currier JS, Lockman S, Aweeka FT, AIDS Clinical Trials Group Study 5208 Team. PMID: 22301417; PMCID: PMC3506024.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCTClinical Trials
    235. The frequency of malaria is similar among women receiving either lopinavir/ritonavir or nevirapine-based antiretroviral treatment. PLoS One. 2012; 7(4):e34399. Skinner-Adams TS, Butterworth AS, Porter KA, D'Amico R, Sawe F, Shaffer D, Siika A, Hosseinipour MC, Stringer E, Currier JS, Chipato T, Salata R, Lockman S, Eron JJ, Meshnick SR, McCarthy JS. PMID: 22509297; PMCID: PMC3317955.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    236. HIV-1 protease inhibitors and clinical malaria: a secondary analysis of the AIDS Clinical Trials Group A5208 study. Antimicrob Agents Chemother. 2012 Feb; 56(2):995-1000. Porter KA, Cole SR, Eron JJ, Zheng Y, Hughes MD, Lockman S, Poole C, Skinner-Adams TS, Hosseinipour M, Shaffer D, D'Amico R, Sawe FK, Siika A, Stringer E, Currier JS, Chipato T, Salata R, McCarthy JS, Meshnick SR. PMID: 22123685; PMCID: PMC3264273.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCellsCTClinical Trials
    237. A biochemical fluorometric method for assessing the oxidative properties of HDL. J Lipid Res. 2011 Dec; 52(12):2341-2351. Kelesidis T, Currier JS, Huynh D, Meriwether D, Charles-Schoeman C, Reddy ST, Fogelman AM, Navab M, Yang OO. PMID: 21957198; PMCID: PMC3220300.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansAnimalsCells
    238. Health-related quality of life in the gender, race, and clinical experience trial. AIDS Res Treat. 2011; 2011:349165. Feinberg J, Saag M, Squires K, Currier J, Ryan R, Coate B, Mrus J. PMID: 21904672; PMCID: PMC3166720.
      View in: PubMed   Mentions: 5  
    239. Participation of women in HIV clinical trials: the IPEC-FIOCRUZ experience. HIV AIDS (Auckl). 2011; 3:61-8. Lake JE, Friedman RK, Cunha CB, Cardoso SW, Veloso VG, Currier JS, Grinsztejn B. PMID: 22096408; PMCID: PMC3218707.
      View in: PubMed   Mentions: 1  
    240. Regional fat deposition and cardiovascular risk in HIV infection: the FRAM study. AIDS Care. 2011 Aug; 23(8):929-38. Lake JE, Wohl D, Scherzer R, Grunfeld C, Tien PC, Sidney S, Currier JS. PMID: 21767228; PMCID: PMC3249238.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    241. Recruitment and retention of diverse populations in antiretroviral clinical trials: practical applications from the gender, race and clinical experience study. J Womens Health (Larchmt). 2011 Jul; 20(7):1043-50. Falcon R, Bridge DA, Currier J, Squires K, Hagins D, Schaible D, Ryan R, Mrus J, GRACE Study Group. PMID: 21663416; PMCID: PMC3130514.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    242. Baseline immune phenotypes and CD4+ T lymphocyte responses to antiretroviral therapy in younger versus older HIV-infected individuals. J Clin Immunol. 2011 Oct; 31(5):873-81. Hoffman RM, Jamieson BD, Bosch RJ, Currier J, Kitchen CM, Schmid I, Zhu Y, Bennett K, Mitsuyasu R. PMID: 21643890; PMCID: PMC3194061.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    243. Effects of darunavir/ritonavir-based therapy on metabolic and anthropometric parameters in women and men over 48 weeks. AIDS Patient Care STDS. 2011 Jun; 25(6):333-40. Currier JS, Martorell C, Osiyemi O, Yin MT, Ryan R, De La Rosa G, Mrus J. PMID: 21612545; PMCID: PMC3143406.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    244. Association of ongoing drug and alcohol use with non-adherence to antiretroviral therapy and higher risk of AIDS and death: results from ACTG 362. AIDS Care. 2011 Jun; 23(6):775-85. Cohn SE, Jiang H, McCutchan JA, Koletar SL, Murphy RL, Robertson KR, de St Maurice AM, Currier JS, Williams PL. PMID: 21293986; PMCID: PMC3095689.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    245. Role of low-frequency HIV-1 variants in failure of nevirapine-containing antiviral therapy in women previously exposed to single-dose nevirapine. Proc Natl Acad Sci U S A. 2011 May 31; 108(22):9202-7. Boltz VF, Zheng Y, Lockman S, Hong F, Halvas EK, McIntyre J, Currier JS, Chibowa MC, Kanyama C, Nair A, Owino-Ong'or W, Hughes M, Coffin JM, Mellors JW. PMID: 21576473; PMCID: PMC3107269.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansCells
    246. Complications of HIV disease and antiretroviral therapy. Top Antivir Med. 2011 May-Jun; 19(2):58-68. Luetkemeyer AF, Havlir DV, Currier JS. PMID: 21868823; PMCID: PMC6148948.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    247. Pregnancy rates and predictors in women with HIV/AIDS in Rio de Janeiro, Southeastern Brazil. Rev Saude Publica. 2011 Apr; 45(2):373-81. Friedman RK, Bastos FI, Leite IC, Veloso VG, Moreira RI, Cardoso SW, Andrade AC, Sampaio MC, Currier J, Grinsztejn B. PMID: 21412574.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    248. HIV-1 infected patients with suppressed plasma viremia on treatment have pro-inflammatory HDL. Lipids Health Dis. 2011 Feb 23; 10:35. Kelesidis T, Yang OO, Currier JS, Navab K, Fogelman AM, Navab M. PMID: 21345230; PMCID: PMC3049748.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    249. First-line antiretroviral therapy after single-dose nevirapine exposure in South Africa: a cost-effectiveness analysis of the OCTANE trial. AIDS. 2011 Feb 20; 25(4):479-92. Ciaranello AL, Lockman S, Freedberg KA, Hughes M, Chu J, Currier J, Wood R, Holmes CB, Pillay S, Conradie F, McIntyre J, Losina E, Walensky RP, CEPAC-International and OCTANE Investigators. PMID: 21293199; PMCID: PMC3068908.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansPHPublic Health
    250. Sex differences in lopinavir and ritonavir pharmacokinetics among HIV-infected women and men. J Clin Pharmacol. 2011 Dec; 51(12):1665-73. Umeh OC, Currier JS, Park JG, Cramer Y, Hermes AE, Fletcher CV. PMID: 21233301; PMCID: PMC3325020.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    251. Sex-associated differences in pre-antiretroviral therapy plasma HIV-1 RNA in diverse areas of the world vary by CD4(+) T-cell count. Antivir Ther. 2011; 16(7):1057-62. Grinsztejn B, Smeaton L, Barnett R, Klingman K, Hakim J, Flanigan T, Kumarasamy N, Campbell T, Currier J, PEARLS study team of the ACTG. PMID: 22024521; PMCID: PMC3205462.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    252. Maternal outcomes after HAART for the prevention of mother-to-child transmission in HIV-infected women in Brazil. Antivir Ther. 2011; 16(3):349-56. Pilotto JH, Velasque LS, Friedman RK, Moreira RI, Veloso VG, Grinsztejn B, Morgado MG, Watts DH, Currier JS, Hoffman RM. PMID: 21555817; PMCID: PMC3437753.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCellsPHPublic Health
    253. Switching antiretroviral therapy to minimize metabolic complications. HIV Ther. 2010 Nov; 4(6):693-711. Lake JE, Currier JS. PMID: 22171239; PMCID: PMC3236090.
      View in: PubMed   Mentions: 6  
    254. A randomized, placebo-controlled trial of abacavir intensification in HIV-1-infected adults with virologic suppression on a protease inhibitor-containing regimen. HIV Clin Trials. 2010 Nov-Dec; 11(6):312-24. Hammer SM, Ribaudo H, Bassett R, Mellors JW, Demeter LM, Coombs RW, Currier J, Morse GD, Gerber JG, Martinez AI, Spreen W, Fischl MA, Squires KE, AIDS Clinical Trials Group (ACTG) 372A Study Team. PMID: 21239359; PMCID: PMC3108099.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    255. Uridine supplementation in the treatment of HIV lipoatrophy: results of ACTG 5229. AIDS. 2010 Oct 23; 24(16):2507-15. McComsey GA, Walker UA, Budhathoki CB, Su Z, Currier JS, Kosmiski L, Naini LG, Charles S, Medvik K, Aberg JA, AIDS Clinical Trials Group A5229 Team. PMID: 20827170; PMCID: PMC2956768.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCellsCTClinical Trials
    256. Antiretroviral therapies in women after single-dose nevirapine exposure. N Engl J Med. 2010 Oct 14; 363(16):1499-509. Lockman S, Hughes MD, McIntyre J, Zheng Y, Chipato T, Conradie F, Sawe F, Asmelash A, Hosseinipour MC, Mohapi L, Stringer E, Mngqibisa R, Siika A, Atwine D, Hakim J, Shaffer D, Kanyama C, Wools-Kaloustian K, Salata RA, Hogg E, Alston-Smith B, Walawander A, Purcelle-Smith E, Eshleman S, Rooney J, Rahim S, Mellors JW, Schooley RT, Currier JS, OCTANE A5208 Study Team. PMID: 20942666; PMCID: PMC2994321.
      View in: PubMed   Mentions: 74     Fields:    Translation:HumansCellsPHPublic Health
    257. Sex-based outcomes of darunavir-ritonavir therapy: a single-group trial. Ann Intern Med. 2010 Sep 21; 153(6):349-57. Currier J, Averitt Bridge D, Hagins D, Zorrilla CD, Feinberg J, Ryan R, Falcon R, Tennenberg A, Mrus J, Squires K, GRACE (Gender, Race, And Clinical Experience) Study Group. PMID: 20855799; PMCID: PMC3056066.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansCellsCTClinical Trials
    258. Associations of antiretroviral drug use and HIV-specific risk factors with carotid intima-media thickness. AIDS. 2010 Sep 10; 24(14):2201-9. Delaney JA, Scherzer R, Biggs ML, Shliplak MG, Polak JF, Currier JS, Kronmal RA, Wanke C, Bacchetti P, O'leary D, Tien PC, Grunfeld C. PMID: 20671544; PMCID: PMC3224487.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    259. Effects of highly active antiretroviral therapy duration and regimen on risk for mother-to-child transmission of HIV in Johannesburg, South Africa. J Acquir Immune Defic Syndr. 2010 May 01; 54(1):35-41. Hoffman RM, Black V, Technau K, van der Merwe KJ, Currier J, Coovadia A, Chersich M. PMID: 20216425; PMCID: PMC2880466.
      View in: PubMed   Mentions: 66     Fields:    Translation:HumansPHPublic Health
    260. Complications of HIV disease and antiretroviral treatment. Top HIV Med. 2010 Apr-May; 18(2):57-65. Luetkemeyer AF, Havlir DV, Currier JS. PMID: 20516525; PMCID: PMC3032798.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    261. Report from the 11th International Workshop on Adverse Drug Reactions and Co-morbidities in HIV. Treatment for patients with central fat accumulation. J Watch AIDS Clin Care. 2010 Mar; 22(3):21-2. Currier J. PMID: 20480623.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    262. Clinical practice. Postexposure prophylaxis for HIV infection. N Engl J Med. 2009 Oct 29; 361(18):1768-75. Landovitz RJ, Currier JS. PMID: 19864675.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansPHPublic Health
    263. Preclinical atherosclerosis due to HIV infection: carotid intima-medial thickness measurements from the FRAM study. AIDS. 2009 Sep 10; 23(14):1841-9. Grunfeld C, Delaney JA, Wanke C, Currier JS, Scherzer R, Biggs ML, Tien PC, Shlipak MG, Sidney S, Polak JF, O'Leary D, Bacchetti P, Kronmal RA. PMID: 19455012; PMCID: PMC3156613.
      View in: PubMed   Mentions: 156     Fields:    Translation:Humans
    264. Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 update by the HIV medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2009 Sep 01; 49(5):651-81. Aberg JA, Kaplan JE, Libman H, Emmanuel P, Anderson JR, Stone VE, Oleske JM, Currier JS, Gallant JE, HIV Medicine Association of the Infectious Diseases Society of America. PMID: 19640227.
      View in: PubMed   Mentions: 148     Fields:    Translation:Humans
    265. Update on cardiovascular complications in HIV infection. Top HIV Med. 2009 Jul-Aug; 17(3):98-103. Currier JS. PMID: 19675367.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    266. Availability of HIV postexposure prophylaxis services in Los Angeles County. Clin Infect Dis. 2009 Jun 01; 48(11):1624-7. Landovitz RJ, Combs KB, Currier JS. PMID: 19400685; PMCID: PMC2922974.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    267. Complications of HIV disease and antiretroviral therapy. Top HIV Med. 2009 Apr-May; 17(2):57-67. Currier JS, Havlir DV. PMID: 19401608.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    268. Lymphoma diagnosis and plasma Epstein-Barr virus load during vicriviroc therapy: results of the AIDS Clinical Trials Group A5211. Clin Infect Dis. 2009 Mar 01; 48(5):642-9. Tsibris AM, Paredes R, Chadburn A, Su Z, Henrich TJ, Krambrink A, Hughes MD, Aberg JA, Currier JS, Tashima K, Godfrey C, Greaves W, Flexner C, Skolnik PR, Wilkin TJ, Gulick RM, Kuritzkes DR. PMID: 19191652; PMCID: PMC2756462.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCellsCTClinical Trials
    269. Determinants of participation in HIV clinical trials: the importance of patients' trust in their provider. HIV Clin Trials. 2009 Mar-Apr; 10(2):104-9. Volkmann ER, Claiborne D, Currier JS. PMID: 19487180.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    270. Lipoprotein Changes in HIV-Infected Antiretroviral-Naïve Individuals after Starting Antiretroviral Therapy: ACTG Study A5152s Stein: Lipoprotein Changes on Antiretroviral Therapy. J Clin Lipidol. 2008 Dec; 2(6):464-471. Stein JH, Komarow L, Cotter BR, Currier JS, Dubé MP, Fichtenbaum CJ, Gerschenson M, Mitchell CK, Murphy RL, Squires K, Parker RA, Torriani FJ, ACTG 5152s Study Team. PMID: 19956354; PMCID: PMC2636959.
      View in: PubMed   Mentions: 13     Fields:    
    271. Safety and efficacy of initiating highly active antiretroviral therapy in an integrated antenatal and HIV clinic in Johannesburg, South Africa. J Acquir Immune Defic Syndr. 2008 Nov 01; 49(3):276-81. Black V, Hoffman RM, Sugar CA, Menon P, Venter F, Currier JS, Rees H. PMID: 18845949; PMCID: PMC2893046.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCellsPHPublic Health
    272. Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: The ACTG (AIDS Clinical Trials Group) Study 5152s. J Am Coll Cardiol. 2008 Aug 12; 52(7):569-76. Torriani FJ, Komarow L, Parker RA, Cotter BR, Currier JS, Dubé MP, Fichtenbaum CJ, Gerschenson M, Mitchell CK, Murphy RL, Squires K, Stein JH, ACTG 5152s Study Team. PMID: 18687253; PMCID: PMC2603599.
      View in: PubMed   Mentions: 154     Fields:    Translation:HumansCells
    273. Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapy. Circulation. 2008 Jul 08; 118(2):e29-35. Currier JS, Lundgren JD, Carr A, Klein D, Sabin CA, Sax PE, Schouten JT, Smieja M, Working Group 2. PMID: 18566319; PMCID: PMC5153327.
      View in: PubMed   Mentions: 152     Fields:    Translation:Humans
    274. State of the science conference: Initiative to decrease cardiovascular risk and increase quality of care for patients living with HIV/AIDS: executive summary. Circulation. 2008 Jul 08; 118(2):198-210. Grinspoon SK, Grunfeld C, Kotler DP, Currier JS, Lundgren JD, Dubé MP, Lipshultz SE, Hsue PY, Squires K, Schambelan M, Wilson PW, Yarasheski KE, Hadigan CM, Stein JH, Eckel RH. PMID: 18566320; PMCID: PMC3642216.
      View in: PubMed   Mentions: 78     Fields:    Translation:Humans
    275. Calcification of the internal elastic lamina of coronary arteries. Mod Pathol. 2008 Aug; 21(8):1019-28. Micheletti RG, Fishbein GA, Currier JS, Singer EJ, Fishbein MC. PMID: 18536656; PMCID: PMC7029955.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    276. Guidelines for managing cardiovascular risk: an evolving area. Curr Opin HIV AIDS. 2008 May; 3(3):205-6. Currier JS, Lundgren JD. PMID: 19372967.
      View in: PubMed   Mentions: 3     Fields:    
    277. Regional adipose tissue and lipid and lipoprotein levels in HIV-infected women. J Acquir Immune Defic Syndr. 2008 May 01; 48(1):35-43. Currier J, Scherzer R, Bacchetti P, Heymsfield S, Lee D, Sidney S, Tien PC, Fat Redistribution and Metabolic Changes in HIV Infection Study Investigators. PMID: 18197118; PMCID: PMC2776070.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    278. Risk of myocardial infarction and nucleoside analogues. Lancet. 2008 Apr 26; 371(9622):1391-2. Stein JH, Currier JS. PMID: 18387666.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    279. Highlights of the 15th Conference on Retroviruses and Opportunistic Infections. Complications of HIV disease and therapy. Top HIV Med. 2008 Apr-May; 16(1):23-30. Currier JS, Havlir DV. PMID: 18441380.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    280. Coronary atherosclerotic lesions in human immunodeficiency virus-infected patients: a histopathologic study. Cardiovasc Pathol. 2009 Jan-Feb; 18(1):28-36. Micheletti RG, Fishbein GA, Fishbein MC, Singer EJ, Weiss RE, Jeffries RA, Currier JS. PMID: 18402832; PMCID: PMC7058188.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    281. Primary human immunodeficiency virus type 1 (HIV-1) infection during HIV-1 Gag vaccination. J Virol. 2008 Mar; 82(6):2784-91. Balamurugan A, Lewis MJ, Kitchen CM, Robertson MN, Shiver JW, Daar ES, Pitt J, Ali A, Ng HL, Currier JS, Yang OO. PMID: 18199650; PMCID: PMC2259011.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    282. Antiviral activity and safety of aplaviroc with lamivudine/zidovudine in HIV-infected, therapy-naive patients: the ASCENT (CCR102881) study. Antivir Ther. 2008; 13(2):297-306. Currier J, Lazzarin A, Sloan L, Clumeck N, Slims J, McCarty D, Steel H, Kleim JP, Bonny T, Millard J, ASCENT study team. PMID: 18505181.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    283. Mönckeberg sclerosis revisited: a clarification of the histologic definition of Mönckeberg sclerosis. Arch Pathol Lab Med. 2008 Jan; 132(1):43-7. Micheletti RG, Fishbein GA, Currier JS, Fishbein MC. PMID: 18181672.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    284. The safety of antiretroviral drugs. Expert Opin Drug Saf. 2008 Jan; 7(1):1-4. Tymchuk CN, Currier JS. PMID: 18171309.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    285. Evaluation of sex differences of fosamprenavir (with and without ritonavir) in HIV-infected men and women. HIV Clin Trials. 2007 Nov-Dec; 8(6):371-80. Hoffman RM, Umeh OC, Garris C, Givens N, Currier JS. PMID: 18042502.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    286. Report from the 9th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV. AIDS Clin Care. 2007 Oct; 19(10):91. Currier J. PMID: 18398999.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    287. Atherosclerotic oxalosis in coronary arteries. Cardiovasc Pathol. 2008 Mar-Apr; 17(2):117-23. Fishbein GA, Micheletti RG, Currier JS, Singer E, Fishbein MC. PMID: 18329558; PMCID: PMC2366163.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    288. Sex differences in antiretroviral therapy toxicity: lactic acidosis, stavudine, and women. Clin Infect Dis. 2007 Jul 15; 45(2):261-2. Currier JS. PMID: 17578789.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    289. HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients. AIDS. 2007 May 31; 21(9):1109-17. McCutchan JA, Wu JW, Robertson K, Koletar SL, Ellis RJ, Cohn S, Taylor M, Woods S, Heaton R, Currier J, Williams PL. PMID: 17502721.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCells
    290. Progression of carotid artery intima-media thickening in HIV-infected and uninfected adults. AIDS. 2007 May 31; 21(9):1137-45. Currier JS, Kendall MA, Henry WK, Alston-Smith B, Torriani FJ, Tebas P, Li Y, Hodis HN. PMID: 17502724.
      View in: PubMed   Mentions: 63     Fields:    Translation:Humans
    291. Report from the 14th Retrovirus Conference. Metabolic complications: lipoatrophy, lipohypertrophy, and cardiovascular risk. AIDS Clin Care. 2007 May; 19(5):40-1. Currier J. PMID: 18398989.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    292. Complications of HIV disease and therapy. Top HIV Med. 2007 Apr-May; 15(2):40-7. Currier JS, Havlir DV. PMID: 17485786.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    293. Management of antiretroviral treatment-related complications. Infect Dis Clin North Am. 2007 Mar; 21(1):103-32, ix. Hoffman RM, Currier JS. PMID: 17502232.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    294. Getting smarter--the toxicity of undertreated HIV infection. N Engl J Med. 2006 Nov 30; 355(22):2359-61. Currier JS, Baden LR. PMID: 17135590.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    295. Assessing sexually transmitted infections in a cohort of women living with HIV/AIDS, in Rio de Janeiro, Brazil. Int J STD AIDS. 2006 Jul; 17(7):473-8. Grinsztejn B, Bastos FI, Veloso VG, Friedman RK, Pilotto JH, Schechter M, Derrico M, Andrade A, Lourenço MC, Moreira RI, Russomano F, Morgado M, Currier JS. PMID: 16820078.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    296. Sex differences in pharmacokinetics and toxicity of antiretroviral therapy. Expert Opin Drug Metab Toxicol. 2006 Apr; 2(2):273-83. Umeh OC, Currier JS. PMID: 16866613.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    297. Report from the 13th retrovirus conference. Metabolic complications and cardiovascular disease. AIDS Clin Care. 2006 Apr; 18(4):36-7. Currier J. PMID: 16718880.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    298. Complications of HIV disease and antiretroviral therapy. Top HIV Med. 2006 Mar-Apr; 14(1):27-35. Havlir DV, Currier JS. PMID: 16641525.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    299. Response to: 'carotid intima-media thickness: assessment of sub-clinical atherosclerosis in HIV-infected patients'. AIDS. 2006 Jan 09; 20(2):311. Currier JS, Kendall MA, Henry WK, Torriani FJ, Hodis HN, ACTG 5078 Study Team. PMID: 16511437.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    300. Report from the 7th International Lipodystrophy Meeting. AIDS Clin Care. 2006 Jan; 18(1):11-2. Currier J. PMID: 16555403.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    301. Meeting notes from the 3rd IAS Conference. HIV treatment and risk for metabolic complications. AIDS Clin Care. 2005 Oct; 17(10):95-6. Currier J. PMID: 16276590.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    302. Lipids, metabolic syndrome, and risk factors for future cardiovascular disease among HIV-infected patients. Curr HIV/AIDS Rep. 2005 Aug; 2(3):132-9. Umeh OC, Currier JS. PMID: 16091260.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    303. Carotid artery intima-media thickness and HIV infection: traditional risk factors overshadow impact of protease inhibitor exposure. AIDS. 2005 Jun 10; 19(9):927-33. Currier JS, Kendall MA, Zackin R, Henry WK, Alston-Smith B, Torriani FJ, Schouten J, Mickelberg K, Li Y, Hodis HN, AACTG 5078 Study Team. PMID: 15905673; PMCID: PMC1373680.
      View in: PubMed   Mentions: 63     Fields:    Translation:HumansCells
    304. Effect of nandrolone decanoate therapy on weight and lean body mass in HIV-infected women with weight loss: a randomized, double-blind, placebo-controlled, multicenter trial. Arch Intern Med. 2005 Mar 14; 165(5):578-85. Mulligan K, Zackin R, Clark RA, Alston-Smith B, Liu T, Sattler FR, Delvers TB, Currier JS, AIDS Clinical Trials Group 329 Study Team, National Institute of Allergy and Infectious Diseases Adult AIDS Clinical Trials Group. PMID: 15767536.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    305. Complications of HIV disease and antiretroviral therapy. Top HIV Med. 2005 Mar-Apr; 13(1):16-23. Currier JS, Havlir DV. PMID: 15849369.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    306. Sex Differences in HIV: Natural History, Pharmacokinetics, and Drug Toxicity. Curr Infect Dis Rep. 2005 Jan; 7(1):73-78. Umeh OC, Currier JS. PMID: 15610674.
      View in: PubMed   Mentions: 3  
    307. C-Reactive protein levels over time and cardiovascular risk in HIV-infected individuals suppressed on an indinavir-based regimen: AIDS Clinical Trials Group 5056s. AIDS. 2004 Dec 03; 18(18):2434-7. Henry K, Kitch D, Dube M, Zackin R, Parker RA, Sprecher D, Hammer S, Currier J, Adult AIDS Clinical Trials Group. PMID: 15622323.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCellsCTClinical Trials
    308. HIV health care services for Mexican migrants. J Acquir Immune Defic Syndr. 2004 Nov 01; 37 Suppl 4:S240-51. Solorio MR, Currier J, Cunningham W. PMID: 15722866.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    309. Long-term follow-up of HIV-infected individuals who have significant increases in CD4+ cell counts during antiretroviral therapy. Clin Infect Dis. 2004 Nov 15; 39(10):1500-6. Koletar SL, Williams PL, Wu J, McCutchan JA, Cohn SE, Murphy RL, Lederman HM, Currier JS, AIDS Clinical Trials Group 362 Study Team. PMID: 15546087.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    310. The correlation between plasma concentrations of protease inhibitors, medication adherence and virological outcome in HIV-infected patients. Antivir Ther. 2004 Oct; 9(5):753-61. Yasuda JM, Miller C, Currier JS, Forthal DN, Kemper CA, Beall GN, Tilles JG, Capparelli EV, McCutchan JA, Haubrich RH, California Collaborative Treatment Group. PMID: 15535413.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCellsCTClinical Trials
    311. Meeting report from the XV International AIDS Conference. Metabolic complications. AIDS Clin Care. 2004 Sep; 16(9):73-4. Currier J. PMID: 15540318.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    312. Primary care guidelines for the management of persons infected with human immunodeficiency virus: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2004 Sep 01; 39(5):609-29. Aberg JA, Gallant JE, Anderson J, Oleske JM, Libman H, Currier JS, Stone VE, Kaplan JE, HIV Medicine Association of the Infectious Diseases Society of America. PMID: 15356773.
      View in: PubMed   Mentions: 50     Fields:    Translation:Cells
    313. Report from the 11th conference on retroviruses and opportunistic infections. Neurology of HIV. AIDS Clin Care. 2004 Apr; 16(4):33-4. Currier J. PMID: 15124587.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    314. Report from the 11th conference on retroviruses and opportunistic infections. Metabolic complications. AIDS Clin Care. 2004 Apr; 16(4):29-32. Currier J. PMID: 15124585.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    315. Complications of HIV disease and antiretroviral therapy. Highlights of the 11th Conference on Retroviruses and Opportunistic Infections, February 8-11, 2004, San Francisco, California, USA. Top HIV Med. 2004 Mar-Apr; 12(1):31-45. Currier JS, Havlir DV. PMID: 15111728.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    316. Incomplete immune reconstitution after initiation of highly active antiretroviral therapy in human immunodeficiency virus-infected patients with severe CD4+ cell depletion. J Infect Dis. 2003 Dec 15; 188(12):1794-803. Lederman HM, Williams PL, Wu JW, Evans TG, Cohn SE, McCutchan JA, Koletar SL, Hafner R, Connick E, Valentine FT, McElrath MJ, Roberts NJ, Currier JS, AIDS Clinical Trials Group 889 Study Team. PMID: 14673757.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCellsCTClinical Trials
    317. A randomized trial of nelfinavir and abacavir in combination with efavirenz and adefovir dipivoxil in HIV-1-infected persons with virological failure receiving indinavir. Antivir Ther. 2003 Dec; 8(6):507-18. Hammer SM, Bassett R, Squires KE, Fischl MA, Demeter LM, Currier JS, Mellors JW, Morse GD, Eron JJ, Santana JL, DeGruttola V, ACTG 372B/D Study Team. PMID: 14760884.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCellsCTClinical Trials
    318. A prospective, randomized trial examining the efficacy and safety of clarithromycin in combination with ethambutol, rifabutin, or both for the treatment of disseminated Mycobacterium avium complex disease in persons with acquired immunodeficiency syndrome. Clin Infect Dis. 2003 Nov 01; 37(9):1234-43. Benson CA, Williams PL, Currier JS, Holland F, Mahon LF, MacGregor RR, Inderlied CB, Flexner C, Neidig J, Chaisson R, Notario GF, Hafner R, AIDS Clinical Trials Group 223 Protocol Team. PMID: 14557969.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCellsCTClinical Trials
    319. Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: recommendations of the HIV Medical Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group. Clin Infect Dis. 2003 Sep 01; 37(5):613-27. Dubé MP, Stein JH, Aberg JA, Fichtenbaum CJ, Gerber JG, Tashima KT, Henry WK, Currier JS, Sprecher D, Glesby MJ, Adult AIDS Clinical Trials Group Cardiovascular Subcommittee, HIV Medical Association of the Infectious Disease Society of America. PMID: 12942391.
      View in: PubMed   Mentions: 146     Fields:    Translation:Humans
    320. Coronary heart disease in HIV-infected individuals. J Acquir Immune Defic Syndr. 2003 Aug 01; 33(4):506-12. Currier JS, Taylor A, Boyd F, Dezii CM, Kawabata H, Burtcel B, Maa JF, Hodder S. PMID: 12869840.
      View in: PubMed   Mentions: 194     Fields:    Translation:Humans
    321. Current management challenges in HIV: tolerability of antiretrovirals and metabolic complications. AIDS Patient Care STDS. 2003 May; 17(5):221-33. Hicks C, Currier J, Sax P, Sherer R, Wanke C. PMID: 12816616.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    322. Complications of HIV infection and antiretroviral therapy. Top HIV Med. 2003 May-Jun; 11(3):86-91. Havlir DV, Currier JS. PMID: 12837967.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    323. Report from the Tenth Retrovirus Conference. Metabolic complications. AIDS Clin Care. 2003 Apr; 15(4):36-7. Currier J. PMID: 12712954.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    324. A study of discontinuing maintenance therapy in human immunodeficiency virus-infected subjects with disseminated Mycobacterium avium complex: AIDS Clinical Trial Group 393 Study Team. J Infect Dis. 2003 Apr 01; 187(7):1046-52. Aberg JA, Williams PL, Liu T, Lederman HM, Hafner R, Torriani FJ, Lennox JL, Dube MP, MacGregor RR, Currier JS, AIDS Clinical Trial Group 393 Study Team. PMID: 12660918.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCellsCTClinical Trials
    325. Steady-state pharmacokinetic interaction of modified-dose indinavir and rifabutin. Clin Pharmacol Ther. 2003 Mar; 73(3):159-69. Hamzeh FM, Benson C, Gerber J, Currier J, McCrea J, Deutsch P, Ruan P, Wu H, Lee J, Flexner C, AIDS Clinical Trials Group 365 Study Team. PMID: 12621381.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    326. Cardiovascular risk factors and antiretroviral therapy. N Engl J Med. 2003 Feb 20; 348(8):679-80. Kuritzkes DR, Currier J. PMID: 12594310.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    327. HIV risk behaviors among African American men in Los Angeles County who self-identify as heterosexual. J Acquir Immune Defic Syndr. 2002 Nov 01; 31(3):354-60. Wohl AR, Johnson DF, Lu S, Jordan W, Beall G, Currier J, Simon PA. PMID: 12439213.
      View in: PubMed   Mentions: 43     Fields:    Translation:Humans
    328. Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: recommendations of an International AIDS Society-USA panel. J Acquir Immune Defic Syndr. 2002 Nov 01; 31(3):257-75. Schambelan M, Benson CA, Carr A, Currier JS, Dubé MP, Gerber JG, Grinspoon SK, Grunfeld C, Kotler DP, Mulligan K, Powderly WG, Saag MS, International AIDS Society-USA. PMID: 12439201.
      View in: PubMed   Mentions: 76     Fields:    Translation:HumansCells
    329. HIV Infection in Women: Selected Issues in Pregnancy. Top HIV Med. 2002 Nov-Dec; 10(5):16-20. Currier JS. PMID: 12717051.
      View in: PubMed   Mentions:    Fields:    
    330. Report on the XIV International AIDS Conference. AIDS Clin Care. 2002 Sep; 14(9):77-85. Abdool Karim SS, Currier J, del Rio C, Feinberg J, Friedland GH, Sax PE, Zuger A. PMID: 12236208.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    331. Cardiovascular risk associated with HIV therapy. J Acquir Immune Defic Syndr. 2002 Sep 01; 31 Suppl 1:S16-23; discussion S24-5. Currier JS. PMID: 12218440.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    332. Localized osteomyelitis due to Mycobacterium avium complex in patients with Human Immunodeficiency Virus receiving highly active antiretroviral therapy. Clin Infect Dis. 2002 Jul 01; 35(1):E8-E13. Aberg JA, Chin-Hong PV, McCutchan A, Koletar SL, Currier JS. PMID: 12060894.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    333. Association of adherence to Mycobacterium avium complex prophylaxis and antiretroviral therapy with clinical outcomes in Acquired Immunodeficiency Syndrome. Clin Infect Dis. 2002 Apr 15; 34(8):1129-36. Cohn SE, Kammann E, Williams P, Currier JS, Chesney MA. PMID: 11915003.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    334. Identifying and managing morphologic complications of HIV and HAART. AIDS Read. 2002 Mar; 12(3):114-9, 124-5. Currier J, Carpenter C, Daar E, Kotler D, Wanke C. PMID: 11966241.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    335. Metabolic complications of HIV infection: translating research findings into clinical practice. AIDS Clin Care. 2002 Jan; 14(1):1-2, 8. Currier J. PMID: 11802627.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    336. Management of metabolic complications of therapy. AIDS. 2002; 16 Suppl 4:S171-6. Currier J. PMID: 12699014.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    337. Impact of prophylaxis for Mycobacterium avium complex on bacterial infections in patients with advanced human immunodeficiency virus disease. Clin Infect Dis. 2001 Jun 01; 32(11):1615-22. Currier JS, Williams P, Feinberg J, Becker S, Owens S, Fichtenbaum C, Benson C, Adult Clinical Trial Group. PMID: 11340534.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCellsCTClinical Trials
    338. Discontinuation of Mycobacterium avium complex prophylaxis in patients with antiretroviral therapy-induced increases in CD4+ cell count. A randomized, double-blind, placebo-controlled trial. AIDS Clinical Trials Group 362 Study Team. Ann Intern Med. 2000 Oct 03; 133(7):493-503. Currier JS, Williams PL, Koletar SL, Cohn SE, Murphy RL, Heald AE, Hafner R, Bassily EL, Lederman HM, Knirsch C, Benson CA, Valdez H, Aberg JA, McCutchan JA. PMID: 11015162.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCellsCTClinical Trials
    339. Differences between women and men in adverse events and CD4+ responses to nucleoside analogue therapy for HIV infection. The Aids Clinical Trials Group 175 Team. J Acquir Immune Defic Syndr. 2000 Aug 01; 24(4):316-24. Currier JS, Spino C, Grimes J, Wofsy CB, Katzenstein DA, Hughes MD, Hammer SM, Cotton DJ. PMID: 11015147.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCTClinical Trials
    340. Discontinuing prophylaxis for opportunistic infection: guiding principles. Clin Infect Dis. 2000 Apr; 30 Suppl 1:S66-71. Currier JS. PMID: 10770914.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    Judith's Networks
    Concepts (648)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (110)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCLA Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-5-g94c7c43e on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California